Press Releases



 
Press Releases
  Date Title View
Sep 7, 2018
REDWOOD CITY, Calif., Sept. 7, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced the publication of an updated assessment of breast cancer gene expression profiling tests by the German Institute for Quality and Efficiency in Health Care (IQWiG). In its analysis, IQWiG concluded that, based on results from the TAILORx study, t...
PDF
Aug 2, 2018
REDWOOD CITY, Calif., Aug. 2, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today reported financial results and business progress for the quarter ended June 30, 2018. "We delivered record results in the first half of 2018, including 14 percent growth in revenue and an $8.3 million profit in the second quarter, driven by successfu...
PDF
Jul 26, 2018
REDWOOD CITY, Calif., July 26, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that the company will host a conference call and webcast on Thursday, August 2 at 4:30 p.m. Eastern Time to discuss its second quarter 2018 financial results. The call and webcast will follow the release of the second quarter financial results af...
PDF
Jun 3, 2018
REDWOOD CITY, Calif., June 3, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, successfully defined the benefit of chemotherapy in early-stage breast cancer patients with Oncotype DX Breast Recurrence Score® results of 11 to 25. The long-awa...
PDF
May 30, 2018
REDWOOD CITY, Calif., May 30, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that it will present at the Jefferies 2018 Global Healthcare Conference in New York City on Wednesday, June 6, 2018 at 8:30 a.m. Eastern Time. To access the live and subsequently archived webcast of the presentation, go to the Investor Rela...
PDF
May 21, 2018
REDWOOD CITY, Calif., May 21, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced results from two new studies demonstrating the positive impact of the Oncotype DX® Genomic Prostate Score™ (GPS™) test on risk assessment for better treatment decisions in clinically low-risk prostate cancer patients in real-world...
PDF
May 9, 2018
REDWOOD CITY, Calif., May 9, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that it will present at the Bank of America Merrill Lynch 2018 Health Care Conference in Las Vegas on Wednesday, May 16, 2018 at 3:00 p.m. Pacific Time. To access the live and subsequently archived webcast of the presentation, go to the Inve...
PDF
May 2, 2018
REDWOOD CITY, Calif., May 2, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today reported financial results and business progress for the quarter ended March 31, 2018. "In the first quarter of 2018, we delivered 13 percent growth in revenue and delivered a non-GAAP profit demonstrating continued operating leverage for the 11th con...
PDF
Apr 26, 2018
REDWOOD CITY, Calif., April 26, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) has been informed of the acceptance of the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, for presentation by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN). The trial will be presented during the Plenary Session at the 2018 American ...
PDF
Apr 25, 2018
REDWOOD CITY, Calif., April 25, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that the company will host a conference call and webcast on Wednesday, May 2 at 4:30 p.m. Eastern Time to discuss its first quarter 2018 financial results. The call and webcast will follow the release of the first quarter financial results after...
PDF
Mar 30, 2018
SAN DIEGO and REDWOOD CITY, Calif., March 30, 2018 /PRNewswire/ -- Epic Sciences, Inc. (Epic) and Genomic Health, Inc. (Nasdaq: GHDX) announced today that Palmetto GBA, a Medicare Administrative Contractor (MAC) that assesses molecular diagnostic technologies, has issued a draft local coverage determination (LCD) for the Oncotype DX® AR-V7 Nuc...
PDF
Mar 15, 2018
REDWOOD CITY, Calif., March 15, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) was informed by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) that the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, has achieved sufficient information to render a conclusion regarding the effect of chemotherapy in early-stage brea...
PDF
Mar 8, 2018
REDWOOD CITY, Calif., March 8, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today reported financial results and business progress for the quarter and year ended December 31, 2017. Total revenue was $340.8 million in the full year 2017, compared with $327.9 million in 2016, an increase of 4 percent. U.S. product revenue wa...
PDF
Feb 26, 2018
REDWOOD CITY, Calif., Feb. 26, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced the U.S. commercial launch of the Oncotype DX® AR-V7 Nucleus Detect™ test. The first and only liquid biopsy test of its kind, the Oncotype DX AR-V7 Nucleus Detect test was developed by Epic Sciences to help prolong the lives of men wit...
PDF
Feb 22, 2018
REDWOOD CITY, Calif., Feb. 22, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that the company will host a conference call and webcast on Thursday, March 8 at 8:30 a.m. Eastern Time to discuss its fourth quarter and year-end 2017 financial results. The call and webcast will follow the release of the fourth quarter and year...
PDF
Feb 5, 2018
REDWOOD CITY, Calif., Feb. 5, 2018 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the publication of real-world clinical evidence demonstrating that use of the Oncotype DX® Genomic Prostate Score™ (GPS™) test resulted in significantly higher use of active surveillance at six and 12 months compared to no testing...
PDF
Dec 21, 2017
REDWOOD CITY, Calif., Dec. 21, 2017 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, chairman of the board, chief executive officer and president, will present at the 36th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Monday, January 8, 2018 at 9:00 a.m. Pacific Ti...
PDF
Dec 11, 2017
REDWOOD CITY, Calif., Dec. 11, 2017 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced results of 10 studies that reinforce the unmatched value of the Oncotype DX Breast Recurrence Score® test and Oncotype DX® DCIS Score™ test in optimizing patient treatment across the breast cancer disease continuum. The data were ...
PDF
Dec 6, 2017
REDWOOD CITY, Calif., Dec. 6, 2017 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced a multi-year research collaboration agreement with Janssen Pharmaceuticals to evaluate the Oncotype DX Genomic Prostate Score™ (GPS™) test for their prostate cancer drug pipeline.  As part of the agreement, Genomic Health will test sam...
PDF
Nov 30, 2017
REDWOOD CITY, Calif., Nov. 30, 2017 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that it will present 10 Oncotype DX® studies at the 40th San Antonio Breast Cancer Symposium (SABCS), which is being held December 5-9, 2017. Presentation highlights include: Positive results from an international validation study...
PDF
Nov 28, 2017
REDWOOD CITY, Calif. and CLEVELAND, Nov. 28, 2017 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX), the world's leading provider of genomic-based diagnostic tests, and Cleveland Diagnostics, Inc., a biotechnology company focused on developing next-generation diagnostics technology for the detection of cancers, today announced an exclusive licens...
PDF
Nov 21, 2017
REDWOOD CITY, Calif., Nov. 21, 2017 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that it will present at the 29th Annual Piper Jaffray Healthcare Conference in New York City on Tuesday, November 28, 2017 at 10:30 a.m. Eastern Time. To access the live and subsequently archived webcast of the presentation, go to the Inve...
PDF
Nov 8, 2017
REDWOOD CITY, Calif., Nov. 8, 2017 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today reported financial results and business progress for the quarter ended September 30, 2017. Total revenue was $83.8 million in the third quarter of 2017, compared with $82.3 million in the third quarter of 2016, an increase of 2 percent. Revenue was n...
PDF
Nov 1, 2017
REDWOOD CITY, Calif., Nov. 1, 2017 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that the company will host a conference call and webcast on Wednesday, November 8 at 4:30 p.m. Eastern Time to discuss its third quarter 2017 financial results. The call and webcast will follow the release of the third quarter financial results af...
PDF
Sep 13, 2017
REDWOOD CITY, Calif. and MECHELEN, Belgium, Sept. 13, 2017 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX), the world's leading provider of genomic-based diagnostic tests  and Biocartis Group NV (Euronext Brussels: BCART), an innovative molecular diagnostics company, today announced an exclusive agreement to develop an in vitro diagnostic (IVD)...
PDF
Sep 11, 2017
REDWOOD CITY, Calif., Sept. 11, 2017 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the presentation of new data that provide additional evidence of the unmatched value of the Oncotype DX Breast Recurrence Score® test in accurately predicting outcomes in early-stage breast cancer patients. The data were presented at the 20...
PDF
Aug 31, 2017
REDWOOD CITY, Calif., Aug. 31, 2017 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from four Oncotype DX Breast Recurrence Score® test studies at the European Society for Medical Oncology (ESMO) 2017 Congress. The conference takes place September 8-12 at the IFEMA, Feria de Madrid, in ...
PDF
Aug 30, 2017
REDWOOD CITY, Calif., Aug. 30, 2017 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that it will present at the 2017 Wells Fargo Healthcare Conference in Boston on Wednesday, September 6, 2017 at 9:05 a.m. Eastern Time. To access the live and subsequently archived webcast of the presentation, go to the Investor Relations ...
PDF
Aug 24, 2017
REDWOOD CITY, Calif., Aug. 24, 2017 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) that assesses molecular diagnostic technologies, has issued a positive final Local Coverage Determination (LCD) to expand Medicare coverage of the Oncotype DX® Genomic Prostate Sc...
PDF
Aug 1, 2017
REDWOOD CITY, Calif., Aug. 1, 2017 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today reported financial results and business progress for the quarter ended June 30, 2017. Total revenue was $85.5 million in the second quarter of 2017, compared with $82.0 million in the second quarter of 2016, an increase of 4 percent, and an increase ...
PDF
Jul 20, 2017
REDWOOD CITY, Calif., July 20, 2017 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that the company will host a conference call and webcast on Tuesday, August 1 at 4:30 p.m. Eastern Time to discuss its second quarter 2017 financial results. The call and webcast will follow the release of the second quarter financial results aft...
PDF
Jul 12, 2017
REDWOOD CITY, Calif., July 12, 2017 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that the 15th St. Gallen International Breast Cancer Conference Expert Panel endorsed the use of genomic tests in early-stage breast cancer and recognized the Oncotype DX Breast Recurrence Score® test for its prognostic ability as well as it...
PDF
Jun 2, 2017
REDWOOD CITY, Calif., June 2, 2017 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the presentation of eight studies that provide additional evidence of the value of Oncotype DX® tests in predicting clinically meaningful endpoints and outcomes across multiple cancer types. The data from patients with invasive breast, ductal...
PDF
May 30, 2017
REDWOOD CITY, Calif., May 30, 2017 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from eight Oncotype DX® studies at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, which will take place June 2-6 at McCormick Place in Chicago. These presentations represent data ac...
PDF
May 25, 2017
REDWOOD CITY, Calif., May 25, 2017 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that it will present at the Jefferies 2017 Healthcare Conference in New York City on Tuesday, June 6, 2017 at 4:30 p.m. Eastern Time. To access the live and subsequently archived webcast of the presentation, go to the Investor Relations sec...
PDF
May 13, 2017
REDWOOD CITY, Calif., May 13, 2017 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from two Oncotype DX® Genomic Prostate Score™ (GPS) test analyses based on a prospective, multi-center, 1,200-patient study. Results of one analysis, presented at the American Urological Association (AUA) 2017 Annual Meeting, pr...
PDF
May 12, 2017
REDWOOD CITY, Calif., May 12, 2017 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the presentation of new results from a large, community-based, multi-center clinical validation study conducted at Kaiser Permanente, confirming that the Oncotype DX® Genomic Prostate Score™ (GPS) test is a strong independent predictor ...
PDF
May 10, 2017
REDWOOD CITY, Calif., May 10, 2017 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that it will present at the Bank of America Merrill Lynch 2017 Health Care Conference in Las Vegas on Wednesday, May 17, 2017 at 11:20 a.m. Pacific Time. To access the live and subsequently archived webcast of the presentation, go to the In...
PDF
May 9, 2017
REDWOOD CITY, Calif., May 9, 2017 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended March 31, 2017. Total revenue was $84.0 million in the first quarter of 2017, compared with $80.9 million in the first quarter of 2016, an increase of 4 percent. U.S. produ...
PDF
May 4, 2017
REDWOOD CITY, Calif., May 4, 2017 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) that assesses molecular diagnostic technologies, has issued a draft local coverage determination (LCD) for the Oncotype DX® Genomic Prostate Score™ (GPS). The draft LCD recomm...
PDF
May 4, 2017
REDWOOD CITY, Calif., May 4, 2017 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from four new Oncotype DX® Genomic Prostate Score™ (GPS) studies will be presented at the upcoming American Urological Association (AUA) 2017 Annual Meeting, which will be held May 12-16 in Boston. With new results reporting...
PDF
May 2, 2017
REDWOOD CITY, Calif., May 2, 2017 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that the company will host a conference call and webcast on Tuesday, May 9 at 4:30 p.m. Eastern Time to discuss its first quarter 2017 financial results.  The call and webcast will follow the release of the first quarter financial results after mar...
PDF
Mar 29, 2017
REDWOOD CITY, Calif., March 29, 2017 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the presentation of new results from a large multi-center validation study, which confirmed that the Oncotype DX® Genomic Prostate Score™ (GPS) is a strong independent predictor of metastases at 10 years in prostate cancer patients ac...
PDF
Mar 24, 2017
REDWOOD CITY, Calif., March 24, 2017 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the publication of results from the National Cancer Institute's (NCI) Surveillance, Epidemiology, and End Results (SEER) Registry in the peer-reviewed journal Breast Cancer Research and Treatment, reconfirming the value of the Oncotype DX Breast...
PDF
Mar 20, 2017
REDWOOD CITY, Calif., March 20, 2017 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from 15 Oncotype DX Breast Recurrence Score® studies conducted in 12 countries that provide real-world evidence of the test's ability to change treatment decisions in breast cancer patients. The new findings, presented at the 15th S...
PDF
Feb 28, 2017
REDWOOD CITY, Calif., Feb. 28, 2017 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that Kim Popovits, chairman of the board, chief executive officer and president, will present at the Cowen and Company 37th Annual Health Care Conference at the Marriot Copley Place in Boston on Tuesday, March 7, 2017 at 11:20 a.m. Eastern Time. ...
PDF
Feb 16, 2017
REDWOOD CITY, Calif., Feb. 16, 2017 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) announced today the presentation of results from four studies evaluating the clinical value and utility of its Oncotype DX® Genomic Prostate Score™ (GPS) in the management of early-stage prostate cancer. Collectively, these new data highlight the test...
PDF
Feb 14, 2017
REDWOOD CITY, Calif., Feb. 14, 2017 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter and year ended December 31, 2016. Total revenue was $327.9 million in the full year 2016, compared with $287.5 million in 2015, an increase of 14 percent. U.S. product revenue ...
PDF
Feb 7, 2017
REDWOOD CITY, Calif., Feb. 7, 2017 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, February 14 at 4:30 p.m. Eastern Time to discuss its fourth quarter and year-end 2016 financial results.  The call and webcast will follow the release of the fourth quarter and y...
PDF
Jan 3, 2017
REDWOOD CITY, Calif., Jan. 3, 2017 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, chairman of the board, chief executive officer and president, will present at the 35th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Monday, January 9, 2017 at 11:00 a.m. Pacific Ti...
PDF
Dec 22, 2016
REDWOOD CITY, Calif., Dec. 22, 2016 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that based on unparalleled clinical evidence, the American Joint Committee on Cancer (AJCC) incorporated the Oncotype DX® test in its recently published Eighth Edition AJCC Cancer Staging Manual. Representing a rigorous, multi-disciplinary a...
PDF
Dec 9, 2016
REDWOOD CITY, Calif., Dec. 9, 2016 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced results from multiple studies demonstrating the unparalleled value of the Oncotype DX® test in individualizing breast cancer treatment decisions for patients with various stages of the disease. Presentations included two overviews of prospect...
PDF
Nov 29, 2016
REDWOOD CITY, Calif., Nov. 29, 2016 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that it will present seven Oncotype DX® studies at the 39th CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), which is being held December 6-10, 2016. The study findings reinforce the Company's leadership in individualizing breast cance...
PDF
Nov 3, 2016
REDWOOD CITY, Calif., Nov. 3, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Brad Cole, chief operating officer and chief financial officer, will present at the Credit Suisse 25th Annual Healthcare Conference in Scottsdale, Arizona on Tuesday, November 8, 2016 at 3:30 p.m. Mountain Time. To access the live and...
PDF
Nov 1, 2016
REDWOOD CITY, Calif., Nov. 1, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended September 30, 2016. Total revenue was $82.3 million in the third quarter of 2016, compared with $73.6 million in the third quarter of 2015, an increase of 12 percent. U.S. ...
PDF
Nov 1, 2016
REDWOOD CITY, Calif., Nov. 1, 2016 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced topline results from a large clinical validation study of its biopsy-based Oncotype DX® Genomic Prostate Score™ (GPS). The study, performed in collaboration with a large integrated healthcare system, met its primary endpoint by demonstr...
PDF
Oct 26, 2016
REDWOOD CITY, Calif., Oct. 26, 2016 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced publication in Reviews in Urology of a comprehensive economic analysis of the use of the Oncotype DX® Genomic Prostate ScoreTM (GPS) in low-risk prostate cancer patients. Results showed that use of the GPS results in a net savings of $2,286 ...
PDF
Oct 25, 2016
REDWOOD CITY, Calif., Oct. 25, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, November 1 at 4:30 p.m. Eastern Time to discuss its third quarter 2016 financial results. The call and webcast will follow the release of the third quarter financial results aft...
PDF
Oct 11, 2016
REDWOOD CITY, Calif., Oct. 11, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from its successfully completed analytical validation study of Oncotype SEQ™ Liquid Select, which demonstrated that this liquid biopsy mutation panel is highly sensitive, specific and reproducible. To provide transparent and clinica...
PDF
Oct 10, 2016
REDWOOD CITY, Calif., Oct. 10, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from eight Oncotype DX® Breast Recurrence Score™ (RS) presentations at the European Society for Medical Oncology (ESMO) 2016 Congress in Copenhagen, Denmark, highlighting superior clinical evidence in identifying which patients...
PDF
Sep 28, 2016
REDWOOD CITY, Calif., Sept. 28, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from nine studies at the European Society for Medical Oncology (ESMO) 2016 Congress, which will take place October 7-11 at the Bella Center in Copenhagen, Denmark. The results will include: Analyt...
PDF
Aug 31, 2016
REDWOOD CITY, Calif., Aug. 31, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Chairman of the Board, Chief Executive Officer and President, will present at the 2016 Wells Fargo Healthcare Conference at the Westin Boston Waterfront Hotel in Boston on Wednesday, September 7, 2016 at 4:05 p.m. Eastern Time....
PDF
Aug 2, 2016
REDWOOD CITY, Calif., Aug. 2, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended June 30, 2016. Total revenue was $82.0 million in the second quarter of 2016 and includes $0.1 million in contract revenue, compared with $70.6 million in the second quarter of 20...
PDF
Jul 26, 2016
REDWOOD CITY, Calif., July 26, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, August 2 at 4:30 p.m. Eastern Time to discuss its second quarter 2016 financial results.  The call and webcast will follow the release of the second quarter financial results af...
PDF
Jul 7, 2016
REDWOOD CITY, Calif. and SAN DIEGO, July 7, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) and Epic Sciences, Inc. today announced an exclusive agreement to commercialize Epic Sciences' novel AR-V7 liquid biopsy test in the United States through Genomic Health's world-class commercial channel. The blood-based test detects the V7 variant o...
PDF
Jun 14, 2016
REDWOOD CITY, Calif., June 14, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the commercial launch of Oncotype SEQ™ Liquid Select, the first of several non-invasive liquid biopsy tests that the company plans to deliver through its Oncotype IQ™ Genomic Intelligence Platform. Oncotype SEQ is a blood-based test t...
PDF
Jun 8, 2016
REDWOOD CITY, Calif., June 8, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the publication of results from the National Cancer Institute's (NCI) Surveillance, Epidemiology, and End Results (SEER) Registry in Nature Partner Journals Breast Cancer, a peer-reviewed journal published by Nature. Published results demonstrated...
PDF
Jun 5, 2016
REDWOOD CITY, Calif., June 5, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from seven Oncotype DX® studies being presented at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting. Results include four new analyses from the National Cancer Institute's (NCI) Surveillance, Epidemiology, and End ...
PDF
May 31, 2016
REDWOOD CITY, Calif., May 31, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Brad Cole, Chief Operating Officer and Chief Financial Officer, will present at the Jefferies 2016 Healthcare Conference at the Grand Hyatt in New York City on Tuesday, June 7, 2016 at 8:30 a.m. Eastern Time. To access the live and sub...
PDF
May 26, 2016
REDWOOD CITY, Calif., May 26, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from seven Oncotype DX® studies at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting, which will take place June 3-7 at McCormick Place in Chicago. The results will include: ...
PDF
May 25, 2016
REDWOOD CITY, Calif., May 25, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the Journal of Clinical Oncology, the official journal of the American Society of Clinical Oncology (ASCO), published results from a large study confirming the ability of the Oncotype DX® Breast Recurrence Score™, in combination wi...
PDF
May 4, 2016
REDWOOD CITY, Calif., May 4, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended March 31, 2016. Revenue was $80.9 million in the first quarter of 2016, compared with $68.2 million in the first quarter of 2015, an increase of 19 percent. U.S. revenue wa...
PDF
May 3, 2016
REDWOOD CITY, Calif., May 3, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Chairman of the Board, Chief Executive Officer and President, will present at the Bank of America Merrill Lynch 2016 Health Care Conference at the Encore at Wynn Las Vegas on Tuesday, May 10, 2016 at 3:40 p.m. Pacific Time. ...
PDF
Apr 27, 2016
REDWOOD CITY, Calif., April 27, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Wednesday, May 4 at 4:30 p.m. Eastern Time to discuss its first quarter 2016 financial results.  The call and webcast will follow the release of the first quarter financial results afte...
PDF
Mar 11, 2016
AMSTERDAM, March 11, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced new five-year clinical outcomes results from a large PlanB study, which was highlighted as an oral presentation at the 10th European Breast Cancer Conference (EBCC-10)1 in Amsterdam, Netherlands. The study, conducted by the West German Study Group (WSG), s...
PDF
Mar 9, 2016
REDWOOD CITY, Calif., March 9, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the update of the German Association of Gynecological Oncology's (AGO's) treatment guidelines to recognize Oncotype DX® as the only multi-gene breast cancer test with the highest 1A level of evidence. The AGO guidelines also reconfirmed Onco...
PDF
Mar 2, 2016
REDWOOD CITY, Calif., March 2, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Brad Cole, Chief Operating Officer and Chief Financial Officer, will present at the Cowen and Company 36th Annual Health Care Conference at the Marriot Copley Place in Boston on Wednesday, March 9, 2016 at 8:40 a.m. Eastern Time. To a...
PDF
Mar 1, 2016
REDWOOD CITY, Calif., March 1, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the Journal of Clinical Oncology published clinical outcomes results from PlanB, one of Europe's largest adjuvant studies that utilized the Oncotype DX® breast cancer test to assign treatment. Led by the Women's Healthcare Study Group (...
PDF
Feb 10, 2016
REDWOOD CITY, Calif., Feb. 10, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter and year ended December 31, 2015. Revenue was $74.5 million in the fourth quarter of 2015, compared with $69.1 million in the fourth quarter of 2014, an increase of 8 percent. On a con...
PDF
Feb 3, 2016
REDWOOD CITY, Calif., Feb. 3, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Wednesday, February 10 at 4:30 p.m. Eastern Time to discuss its fourth quarter and year-end 2015 financial results. The call and webcast will follow the release of the fourth quarter and ...
PDF
Jan 11, 2016
REDWOOD CITY, Calif., Jan. 11, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced plans to launch its first liquid biopsy test, Oncotype SEQ™, in mid-2016. The test is a blood-based mutation panel that uses next-generation sequencing to identify select actionable genomic alterations for the treatment of patients with lat...
PDF
Jan 8, 2016
REDWOOD CITY, Calif., Jan. 8, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced preliminary revenue for the year ended December 31, 2015, is expected to be between $285 and $286 million, compared with $275.7 million in 2014, representing an increase of approximately 4 percent, slightly below the Company's 2015 guidance. ...
PDF
Jan 4, 2016
REDWOOD CITY, Calif., Jan. 4, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Chairman, Chief Executive Officer and President, will present at the 34th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Monday, January 11, 2016 at 3:30 p.m. Pacific Time. To...
PDF
Dec 15, 2015
REDWOOD CITY, Calif., Dec. 15, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from multiple Oncotype DX® breast cancer test studies at the 38th CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) reconfirming that Oncotype DX accurately predicts clinical outcomes - including risk of recurrence and breast can...
PDF
Dec 9, 2015
REDWOOD CITY, Calif., Dec. 9, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from eight Oncotype DX® breast cancer test studies at the 38th CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  Presentations in invasive breast cancer, ductal carcinoma in situ (DCIS) and next-gen...
PDF
Nov 18, 2015
REDWOOD CITY, Calif., Nov. 18, 2015 /PRNewswire/ -- On Tuesday, November 17, 2015, the Centers for Medicare and Medicaid Services (CMS), which administers the Medicare program, issued its final Clinical Laboratory Fee Schedule (CLFS) for 2016, which will allow the Medicare Administrative Contractor (MAC) to continue to set payment for the Oncotype ...
PDF
Nov 16, 2015
REDWOOD CITY, Calif., Nov. 16, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from eight Oncotype DX® breast cancer test studies at the 38th CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), taking place December 8-12, 2015 at the Henry B. Gonzalez Convention Center.  Present...
PDF
Nov 3, 2015
REDWOOD CITY, Calif., Nov. 3, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended September 30, 2015. Revenue was $73.6 million in the third quarter of 2015 compared with $69.1 million for the third quarter of 2014, an increase of 6 percent. On a constant curre...
PDF
Nov 3, 2015
REDWOOD CITY, Calif., Nov. 3, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that members of its management team will present at the following conferences in November: Brad Cole, chief operating officer and chief financial officer, will present at the 24th Annual Credit Suisse Healthcare Conference in Phoenix, A...
PDF
Oct 27, 2015
REDWOOD CITY, Calif., Oct. 27, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, November 3 at 4:30 p.m. Eastern Time to discuss its third quarter 2015 financial results. The call and webcast will follow the release of the third quarter financial results aft...
PDF
Oct 15, 2015
REDWOOD CITY, Calif., Oct. 15, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) that assesses molecular diagnostic technologies, has initiated reimbursement coverage of the Oncotype DX® prostate cancer test for qualified Medicare patients throughout the Unite...
PDF
Oct 7, 2015
REDWOOD CITY, Calif., Oct. 7, 2015 /PRNewswire/ -- On Tuesday, October 6, 2015, the Centers for Medicare and Medicaid Services (CMS), which administers the Medicare program, issued updated pricing determinations for the Clinical Laboratory Fee Schedule (CLFS) including a payment rate of $3,416 for the Oncotype DX® breast cancer test.  This is ...
PDF
Sep 28, 2015
REDWOOD CITY, Calif., Sept. 28, 2015 /PRNewswire/ -- On Friday, September 25, 2015, the Centers for Medicare and Medicaid Services (CMS), which administers the Medicare program, released a final payment determination, subject to reconsideration, for the Clinical Laboratory Fee Schedule (CLFS) for the Oncotype DX® breast cancer test, representi...
PDF
Sep 28, 2015
REDWOOD CITY, Calif., Sept. 28, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that, in addition to the positive five-year results from a group of patients with low Oncotype DX® Recurrence Score® results from the watershed ECOG-ACRIN Cancer Research Group's TAILORx (Trial Assigning IndividuaLized Options for Trea...
PDF
Sep 28, 2015
VIENNA and PHILADELPHIA and REDWOOD CITY, Calif., Sept. 28, 2015 /PRNewswire/ -- Initial results were announced today from the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, a multi-center prospectively conducted trial of more than 10,000 women with early stage breast cancer sponsored by the National Cancer Institute (NCI), ...
PDF
Sep 11, 2015
REDWOOD CITY, Calif., Sept. 11, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from four Oncotype DX® breast cancer studies, including three large clinical outcomes studies in which the test was used to determine treatment, will be presented at the 2015 European Cancer Congress (ECC 2015) in Vienna, Austr...
PDF
Aug 20, 2015
Largest Genomic Study in DCIS Shows Genomic Health's Oncotype DX Predicts Local Recurrence, Helps Personalise Treatment of Stage 0 Breast Cancer TORONTO, Aug. 20, 2015 /CNW/ - Genomic Health, Inc. (Nasdaq: GHDX) today announced that Breast Cancer Research and Treatment published results from a second large clinical validation study o...
PDF
Aug 17, 2015
REDWOOD CITY, Calif., Aug. 17, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) that assesses molecular diagnostic technologies, has issued its final local coverage determination (LCD) approving coverage of the Oncotype DX® prostate cancer test for qualified ...
PDF
Aug 4, 2015
REDWOOD CITY, Calif., Aug. 4, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended June 30, 2015. Revenue was $70.6 million in the second quarter of 2015 compared with $70.5 million for the second quarter of 2014. International revenue was $9.9 million i...
PDF
Jul 30, 2015
REDWOOD CITY, Calif., July 30, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Urology Practice published results from the second clinical utility study of the Oncotype DX® prostate cancer test, showing that incorporation of the test's Genomic Prostate Score (GPS) in treatment planning resulted in greater recommen...
PDF
Jul 28, 2015
REDWOOD CITY, Calif., July 28, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, August 4 at 4:30 p.m. Eastern Time to discuss its second quarter 2015 financial results. The call and webcast will follow the release of the second quarter financial results aft...
PDF
Jul 14, 2015
REDWOOD CITY, Calif., July 14, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Breast Cancer Research and Treatment published results from a second large clinical validation study of Oncotype DX® in patients with stage 0 breast cancer, also known as DCIS (ductal carcinoma in situ). The population-based study, cond...
PDF
Jun 23, 2015
REDWOOD CITY, Calif., June 23, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the Journal of Surgical Oncology published results from a multi-center study of the Oncotype DX® DCIS Score™, demonstrating the test has significant impact on the treatment recommendations for patients with ductal carcinoma in sit...
PDF
Jun 16, 2015
REDWOOD CITY, Calif., June 16, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results from a liquid biopsy proof-of-concept study demonstrating its ability to more conveniently detect disease recurrence with a level of accuracy comparable to cystoscopy, an invasive procedure for surveillance of early-stage bladder...
PDF
Jun 11, 2015
REDWOOD CITY, Calif., June 11, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from a multi-center, proof-of-concept, bladder cancer liquid biopsy study will be presented at the American Association for Cancer Research (AACR) Precision Medicine Meeting in Salt Lake City. The study was co-led by Genomic Health, ...
PDF
Jun 1, 2015
REDWOOD CITY, Calif., June 1, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from multiple Oncotype DX® studies presented at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting. The presentations reinforce the robustness of the Oncotype DX tests across invasive breast cancer, ductal carcinoma ...
PDF
May 27, 2015
REDWOOD CITY, Calif., May 27, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from four Oncotype DX® studies will be presented at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, which will take place May 29-June 2 at McCormick Place in Chicago. The results highlight the following: ...
PDF
May 27, 2015
REDWOOD CITY, Calif., May 27, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Brad Cole, Chief Operating Officer and Chief Financial Officer, will present at the Jefferies 2015 Global Healthcare Conference in New York City on Monday, June 1 at 8:30 a.m. Eastern Time (ET). To access the live and subsequently arch...
PDF
May 21, 2015
REDWOOD CITY, Calif., May 21, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) that assesses molecular diagnostic technologies, has issued a draft local coverage determination (LCD) for the Oncotype DX® prostate cancer test. The draft LCD recommends coverage ...
PDF
May 20, 2015
REDWOOD CITY, Calif., May 20, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from a study led by the University of California, San Francisco (UCSF) showing a broad distribution of Oncotype DX® Genomic Prostate Score (GPS) results among prostate MRI findings, suggesting that these two technologies may provide n...
PDF
May 18, 2015
REDWOOD CITY, Calif., May 18, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results from a second, larger liquid biopsy feasibility study demonstrating the Company's ability to detect tumor-specific DNA in urine, which is expected to enable bladder cancer recurrence monitoring. The study results, which were prese...
PDF
May 15, 2015
REDWOOD CITY, Calif., May 15, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from three studies that show the real-world positive impact of the Oncotype DX® Genomic Prostate Score (GPS) and the test's value in managing healthcare costs associated with treatment decisions in low-risk patients. The data were pre...
PDF
May 11, 2015
REDWOOD CITY, Calif., May 11, 2015 /PRNewswire/ -- Genomic Health (Nasdaq: GHDX) today announced that the 14th St. Gallen International Breast Cancer Conference Expert Panel, for the third time, recognized the Oncotype DX® breast cancer test for its ability to provide not only prognostic but also predictive information regarding the likelihood...
PDF
May 7, 2015
REDWOOD CITY, Calif., May 7, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from five studies will be presented at the American Urological Association Annual Meeting, which will take place May 15-19 at the New Orleans Ernest N. Morial Convention Center. Poster discussions will include studies supporting wider ...
PDF
May 6, 2015
REDWOOD CITY, Calif., May 6, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Chairman of the Board, Chief Executive Officer & President, will present at the Bank of America Merrill Lynch 2015 Healthcare Conference in Las Vegas on Tuesday, May 12 at 3:40 p.m. Pacific Time (PT). To access the live an...
PDF
May 5, 2015
REDWOOD CITY, Calif., May 5, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended March 31, 2015. Product revenue was $68.2 million in the first quarter of 2015, compared with $67.0 million for the first quarter of 2014, an increase of 2 percent.  On a constant ...
PDF
Apr 30, 2015
REDWOOD CITY, Calif., April 30, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Urology Practice, an official journal of the American Urological Association (AUA), published positive results from the first decision impact study of the Oncotype DX® prostate cancer test. Results showed that use of the test substanti...
PDF
Apr 28, 2015
REDWOOD CITY, Calif., April 28, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, May 5 at 4:30 p.m. Eastern Time to discuss its first quarter 2015 financial results.  The call and webcast will follow the release of the first quarter results after market clo...
PDF
Mar 20, 2015
REDWOOD CITY, Calif., March 20, 2015 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that 11 studies were presented at the 14th St. Gallen International Breast Cancer Conference, including positive results from a real-life observational study in Ireland.1 That study demonstrated that use of the Oncotype DX® test in early-st...
PDF
Feb 10, 2015
REDWOOD CITY, Calif., Feb. 10, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter and year ended December 31, 2014. Product revenue was $69.1 million in the fourth quarter of 2014, compared with $67.1 million for the fourth quarter of 2013, an increase of 3 percent....
PDF
Feb 5, 2015
REDWOOD CITY, Calif., Feb. 5, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) announced today that, as of April 1, 2015, the Oncotype DX® test will be available to eligible breast cancer patients through the National Health Service (NHS) in England as the only multi-gene breast cancer test recommended by the National Institute for Hea...
PDF
Feb 3, 2015
REDWOOD CITY, Calif., Feb. 3, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, February 10 at 4:30 p.m. Eastern Time to discuss its fourth quarter and year-end 2014 financial results.  The call and webcast will follow the release of the fourth quarter and y...
PDF
Jan 5, 2015
REDWOOD CITY, Calif., Jan. 5, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Chairman, Chief Executive Officer and President, will present at the 33rd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Monday, January 12 at 8:30 am Pacific Time (PT). To ac...
PDF
Dec 12, 2014
SAN ANTONIO, Dec. 12, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results from the second large clinical validation study of Oncotype DX® in patients with a pre-invasive form of breast cancer known as DCIS (ductal carcinoma in situ).  The study, conducted by the Ontario DCIS Study Group of Sunnybrook Healt...
PDF
Dec 10, 2014
SAN ANTONIO, Dec. 10, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced early results from Europe's largest contemporary adjuvant breast cancer trial, which used the Oncotype DX® breast cancer test to identify higher-risk patients who would benefit from the treatment. The early results of the study, conducted by the Wome...
PDF
Dec 9, 2014
SAN ANTONIO, Dec. 9, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results from its first two feasibility studies assessing multiple technologies, including next-generation sequencing, for their ability to detect and characterize the presence of bladder cancer DNA in urine and breast cancer DNA in blood.  ...
PDF
Dec 3, 2014
REDWOOD CITY, Calif., Dec. 3, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from two studies of the Oncotype DX® prostate cancer test demonstrating its value in low- and intermediate-risk prostate cancer to enable physicians and patients to avoid over- and under-treatment of the disease.  Both studies will be...
PDF
Dec 2, 2014
REDWOOD CITY, Calif., Dec. 2, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that positive results from the second large, independent clinical validation study of Oncotype DX® in patients with DCIS (ductal carcinoma in situ) breast cancer will be featured in the press program of the 37th Annual San Antonio Breast Canc...
PDF
Nov 26, 2014
REDWOOD CITY, Calif., Nov. 26, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Chairman, Chief Executive Officer and President, will participate in the 26th Annual Piper Jaffray Healthcare Conference at The New York Palace Hotel in New York on Wednesday, December 3 at 11:30 am Eastern Time (ET). To...
PDF
Nov 19, 2014
REDWOOD CITY, Calif., Nov. 19, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced multiple upcoming presentations at the 2014 Society of Urologic Oncology (SUO) Annual Meeting, including the second large, independent clinical validation study of the Oncotype DX® prostate cancer test and results from the first prostate can...
PDF
Nov 4, 2014
REDWOOD CITY, Calif., Nov. 4, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended September 30, 2014. Product revenue was $69.1 million in the third quarter of 2014, compared with $65.7 million for the third quarter of 2013, an increase of 5 percent.  There was...
PDF
Nov 4, 2014
REDWOOD CITY, Calif., Nov. 4, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Brad Cole, Chief Operating Officer and Chief Financial Officer, will present at the Credit Suisse Annual Healthcare Conference in Phoenix, Ariz. on Tuesday, November 11 at 3:00 p.m. Mountain Time (MT). To access the live and subsequent...
PDF
Oct 28, 2014
REDWOOD CITY, Calif., Oct. 28, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, November 4 at 4:30 p.m. Eastern Time to discuss its third quarter 2014 financial results.  The call and webcast will follow the release of the third quarter financial results af...
PDF
Sep 29, 2014
REDWOOD CITY, Calif., Sept. 29, 2014 - Genomic Health, Inc. (Nasdaq: GHDX) today announced strongly positive results from an additional independent clinical validation study of the Oncotype DX® prostate cancer test, conducted in collaboration with the Uniformed Services University of the Health Sciences' (USU) Center for Prostate Disease Researc...
PDF
Sep 26, 2014
REDWOOD CITY, Calif., Sept. 26, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from a second large, independent clinical validation study of Oncotype DX® in patients with a pre-invasive form of breast cancer known as DCIS (ductal carcinoma in situ) will be featured as an oral presentation at the 37th Annu...
PDF
Sep 24, 2014
REDWOOD CITY, Calif., Sept. 24, 2014 /PRNewswire/ -- In partnership with Men's Health Network (MHN), Prostate Health Education Network (PHEN), ZERO - the End of Prostate Cancer and Joe Torre, four-time world champion baseball Hall-of-Famer and prostate cancer survivor, Genomic Health, Inc. (Nasdaq: GHDX) today launched Your Prostate Your Decision t...
PDF
Sep 12, 2014
REDWOOD CITY, Calif., Sept. 12, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that PharmacoEconomics published positive results from a health economic analysis suggesting that use of the Oncotype® DX colon cancer test may result in a significant reduction in direct medical costs and improve patient quality of life by...
PDF
Sep 9, 2014
REDWOOD CITY, Calif., Sept. 9, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from nine studies of Oncotype DX® in prostate, breast and renal cancers will be presented at the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, September 26 - 30. Included in the program is the first prese...
PDF
Aug 8, 2014
REDWOOD CITY, Calif., Aug. 8, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Brad Cole, Chief Operating Officer and Chief Financial Officer, will present at the 34th Annual Canaccord Growth Conference in Boston on Wednesday, August 13 at 10:30 a.m. Eastern Time (ET). To access the live and subsequently arch...
PDF
Aug 7, 2014
REDWOOD CITY, Calif., Aug. 7, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended June 30, 2014. Product revenue was $70.5 million in the second quarter of 2014, compared with $63.7 million for the second quarter of 2013, an increase of 11 percent.  There was n...
PDF
Aug 6, 2014
REDWOOD CITY, Calif., Aug. 6, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive preliminary results from an additional independent clinical validation study conducted by the Center for Prostate Disease Research (CPDR) demonstrating that the Oncotype DX® Genomic Prostate Score (GPS) predicts multiple clinical end...
PDF
Jul 31, 2014
REDWOOD CITY, Calif., July 31, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Thursday, August 7 at 4:30 p.m. Eastern Time to discuss its second quarter 2014 financial results.  The call and webcast will follow the release of the second quarter financial results a...
PDF
Jun 11, 2014
REDWOOD CITY, Calif., June 11, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive preliminary results from a second large, independent clinical validation study of Oncotype DX® in patients with a pre-invasive form of breast cancer, also known as DCIS (ductal carcinoma in situ).  The study, conducted by the Ontari...
PDF
Jun 10, 2014
Demonstrate importance of consistent results from multiple validation studies Highlight substantial differences between multi-gene tests Reinforce Genomic Health's commitment to improving the quality of treatment decisions for cancer patients ...
PDF
Jun 3, 2014
REDWOOD CITY, Calif., June 3, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of two studies demonstrating the ability of its Oncotype DX® test and a new 16-gene panel to predict disease aggressiveness and clinical outcomes in prostate and renal cancers, respectively. These results, presented at the American So...
PDF
Jun 1, 2014
REDWOOD CITY, Calif., June 1, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of six studies being presented at the 2014 American Society of Clinical Oncology® (ASCO®) Annual Meeting taking place May 30 - June 3 in Chicago, underscoring the practice-changing value of Oncotype DX® in pre-invasive and i...
PDF
May 29, 2014
REDWOOD CITY, Calif., May 29, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of a large, positive study that confirmed that the Oncotype DX® test results for Recurrence Score® and quantitative estrogen-receptor (ER) predict late distant recurrence risk in early-stage breast cancer patients after initial t...
PDF
May 23, 2014
REDWOOD CITY, Calif., May 23, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that members of its management team will present at the following conferences in June: Jefferies 2014 Global Healthcare Conference on Monday, June 2 at 4:00 p.m. Eastern Time (ET) in New York City; and Goldman Sachs 35th Annual Glob...
PDF
May 20, 2014
REDWOOD CITY, Calif., May 20, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today presented positive results reinforcing the robustness of the Oncotype DX® prostate cancer test's development as a predictor of prostate cancer aggressiveness. A sub-analysis of a large Oncotype DX Genomic Prostate Score (GPS) development study, present...
PDF
May 16, 2014
REDWOOD CITY, Calif., May 16, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) announced today that groundbreaking results from three studies of the Oncotype DX® prostate cancer test were published in European Urology. The peer-reviewed publication highlights studies that focus on addressing the need of the large proportion of prostate...
PDF
May 14, 2014
REDWOOD CITY, Calif., May 14, 2014 /PRNewswire/ -- In response to continued advances in genomic technology and genetic medicine, the National Institutes of Health (NIH) has developed the Genetic Testing Registry (GTR), a free online resource, to provide physicians, researchers and patients with detailed and accurate information about genetic and ge...
PDF
May 6, 2014
REDWOOD CITY, Calif., May 6, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended March 31, 2014. Logo - http://photos.prnewswire.com/prnh/20130425/SF01493LOGO Product revenue was $67.0 million in the first quarter of 2014, compared with $62.7 million for...
PDF
May 5, 2014
REDWOOD CITY, Calif., May 5, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from nine studies of Oncotype DX® in breast, colon, prostate and renal cancer will be presented at the American Society of Clinical Oncology® (ASCO®) Annual Meeting, taking place May 30 - June 3, 2014 at McCormick Place ...
PDF
May 2, 2014
REDWOOD CITY, Calif., May 2, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that The Oncologist published positive results from an Oncotype DX® colon cancer decision impact study, demonstrating that Recurrence Score® results changed treatment recommendations in 45 percent of stage II colon cancer patients. The st...
PDF
Apr 29, 2014
REDWOOD CITY, Calif., April 29, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, May 6 at 4:30 p.m. Eastern Time to discuss its first quarter 2014 financial results.  The call and webcast will follow the release of the first quarter financial results after ...
PDF
Apr 22, 2014
REDWOOD CITY, Calif., April 22, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced two important international milestones including additional reimbursement in Canada and the inclusion of the Oncotype DX® breast cancer test in major German clinical guidelines.  In Canada, the BC Cancer Agency in British Columbia agreed to...
PDF
Mar 19, 2014
REDWOOD CITY, Calif., March 19, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the presentation of multiple Oncotype DX® breast cancer studies at the 9th European Breast Cancer Conference (EBCC-9), which takes place March 19-21 in Glasgow, Scotland, United Kingdom.  New data will include an independently conducted phy...
PDF
Feb 4, 2014
REDWOOD CITY, Calif., Feb. 4, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter and year ended December 31, 2013. (Logo: http://photos.prnewswire.com/prnh/20130425/SF01493LOGO) Product revenue was $67.1 million in the fourth quarter of 2013, compared with $...
PDF
Jan 29, 2014
REDWOOD CITY, Calif., Jan. 29, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from the Oncotype DX® colon cancer test studies that were recently presented at the 2014 American Society of Clinical Oncology Gastrointestinal Cancer Symposium (ASCO GI).  Presentations highlighted the robust body of clinical eviden...
PDF
Jan 28, 2014
REDWOOD CITY, Calif., Jan. 28, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, February 4 at 4:30 p.m. Eastern Time to discuss its fourth quarter and year-end 2013 financial results.  The call and webcast will follow the release of the fourth quarter finan...
PDF
Jan 6, 2014
REDWOOD CITY, Calif., Jan. 6, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Genomic Health's Chairman, Chief Executive Officer, and President will present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 13 at 8:30 a.m. Pacific Time (PT). To access the live...
PDF
Dec 14, 2013
REDWOOD CITY, Calif., Dec. 14, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from three studies of its Oncotype DX® breast cancer test presented at the 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), reinforcing the unmatched value of the test to patients and physicians worldwide.  Oncotype...
PDF
Dec 4, 2013
REDWOOD CITY, Calif., Dec. 4, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from multiple Oncotype DX® breast cancer test studies at the 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), being held December 10-14, 2013 at the Henry B. Gonzalez Convention Center. ...
PDF
Nov 25, 2013
REDWOOD CITY, Calif. & CRAIGAVON, Northern Ireland--(BUSINESS WIRE)-- Genomic Health, Inc. (Nasdaq: GHDX) and ALMAC GROUP Ltd jointly announced today that Genomic Health will exclusively license Almac Group's technology and intellectual property to further develop, validate and subsequently commercialize a multi-...
PDF
Nov 22, 2013
REDWOOD CITY, Calif., Nov. 22, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that BMC Genomics published positive results from its analytical validation study demonstrating that the Oncotype DX® prostate cancer test is a reliable assay, even with very limited RNA inputs, which enables successful performance using sma...
PDF
Nov 13, 2013
REDWOOD CITY, Calif., Nov. 13, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the Journal of Clinical Oncology (JCO) has published positive results from a large, independent validation study of the Oncotype DX® colon cancer test in patients from the National Surgical Adjuvant Breast and Bowel Project (NSABP) C-07...
PDF
Nov 5, 2013
REDWOOD CITY, Calif., Nov. 5, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended September 30, 2013. (Logo: http://photos.prnewswire.com/prnh/20130425/SF01493LOGO) Product revenue was $65.7 million in the third quarter of 2013, compared with $58.4 milli...
PDF
Nov 5, 2013
REDWOOD CITY, Calif., Nov. 5, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Current Medical Research & Opinion (CMRO) published positive results from the Partnership for Health Analytic Research (PHAR) clinical utility analysis of the Oncotype DX® colon cancer test, demonstrating that use of the assay changes tr...
PDF
Oct 29, 2013
REDWOOD CITY, Calif., Oct. 29, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, November 5 at 4:30 p.m. Eastern Time to discuss its third quarter 2013 financial results.  The call and webcast will follow the release of the third quarter financial results af...
PDF
Oct 1, 2013
AMSTERDAM and REDWOOD CITY, Calif., Oct. 1, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from four studies highlighting the value of its Oncotype DX® tests for optimizing treatment for patients with breast and colon cancer.  Three new decision impact studies - including the company's first international deci...
PDF
Sep 25, 2013
REDWOOD CITY, Calif., Sept. 25, 2013 /PRNewswire/ -- Genomic Health, Inc. today announced that the National Institute for Health and Care Excellence (NICE) in the United Kingdom has issued its final guidance recommending Oncotype DX® as the only multi-gene breast cancer test for use in clinical practice to guide chemotherapy treatment decision...
PDF
Aug 22, 2013
GENEVA and REDWOOD CITY, Calif., Aug. 22, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the 13th St. Gallen International Breast Cancer Conference Expert Panel, for the second time,  recognized the Oncotype DX® breast cancer test for its ability to provide not only prognostic information, but also predictive inf...
PDF
Aug 7, 2013
REDWOOD CITY, Calif., Aug. 7, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that members of its management team will present at the Canaccord Genuity 33rd Annual Growth Conference in Boston on Wednesday, August 14 at 2:00 p.m. Eastern Time (ET). (Logo: http://photos.prnewswire.com/prnh/20130425/SF01493LOGO) ...
PDF
Jul 31, 2013
REDWOOD CITY, Calif., July 31, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended June 30, 2013. (Logo: http://photos.prnewswire.com/prnh/20130425/SF01493LOGO) Product revenue was $63.7 million in the second quarter of 2013, compared with $57.2 million...
PDF
Jul 24, 2013
REDWOOD CITY, Calif., July 24, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Wednesday, July 31 at 4:30 p.m. Eastern Time to discuss its second quarter 2013 financial results.  The call and webcast will follow the release of the second quarter financial results a...
PDF
May 31, 2013
REDWOOD CITY, Calif., May 31, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of 10 studies being presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, underscoring the company's commitment to optimizing cancer treatment.  New data include studies of the Oncotype DX® RT-PCR-based breast,...
PDF
May 28, 2013
REDWOOD CITY, Calif., May 28, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that members of its management team will present at the following conferences in June: Jefferies 2013 Global Healthcare Conference on Monday, June 3 at 4:30 p.m. Eastern Time (ET) in New York City; and Goldman Sachs 34th Annual Glob...
PDF
May 21, 2013
REDWOOD CITY, Calif., May 21, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from ten studies in breast, colon and prostate cancer, including a large next generation sequencing (NGS) study, will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 31 — June 4,...
PDF
May 10, 2013
REDWOOD CITY, Calif., May 10, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that, effective May 8, 2013, Palmetto GBA, the designated national contractor for its Oncotype DX® breast cancer test, has expanded its coverage policy for all qualified Medicare patients to include patients with ductal carcinoma in situ (DCI...
PDF
May 8, 2013
SAN DIEGO, May 8, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) is making its Oncotype DX® prostate cancer test available to physicians and their patients today following the presentation by the University of California, San Francisco (UCSF) of a positive clinical validation study at the 2013 American Urological Association (AUA) An...
PDF
May 7, 2013
REDWOOD CITY, Calif., May 7, 2013 /PRNewswire/ -- Genomic Health, Inc.  (Nasdaq: GHDX) today announced that members of its management team will present at the 2013 Bank of America Merrill Lynch Health Care Conference in Las Vegas on Tuesday, May 14 at 5:00 p.m. Pacific Time (PT).  (Logo: http://photos.prnewswire.com/prnh/20130425/SF01493LOG...
PDF
May 2, 2013
REDWOOD CITY, Calif. and PHILADELPHIA, May 2, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) and the ECOG-ACRIN Cancer Research Group announced today that the Journal of the National Cancer Institute (JNCI) published positive results from their clinical validation study of the Oncotype DX® DCIS Score in patients with ductal carcinoma...
PDF
May 2, 2013
REDWOOD CITY, Calif., May 2, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended March 31, 2013. (Logo: http://photos.prnewswire.com/prnh/20130425/SF01493LOGO) Total revenue for the first quarter of 2013 increased to $63.1 million, compared with $58.5 m...
PDF
May 1, 2013
REDWOOD CITY,Calif., May 1, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that it will host an investor webcast and conference call to discuss the positive development and clinical validation study results of its biopsy-based Oncotype DX prostate cancer test on Wednesday, May 8, 2013 at 1:00 p.m. Pacific Time. (Log...
PDF
Apr 25, 2013
REDWOOD CITY, Calif., April 25, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Thursday, May 2 at 4:30 p.m. Eastern Time to discuss its first quarter 2013 financial results.  The call and webcast will follow the release of the first quarter financial results after...
PDF
Apr 17, 2013
REDWOOD CITY, Calif., April 17, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the Journal of Clinical Oncology (JCO) published positive results from the large CALGB 9581 clinical validation study of the Oncotype DX® colon cancer test in stage II colon cancer patients. The findings provide further confirmation th...
PDF
Apr 3, 2013
REDWOOD CITY, Calif., April 3, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the clinical trial results validating its biopsy-based Oncotype DX® prostate cancer test will be presented by investigators from the University of California, San Francisco (UCSF) in an oral session at the American Urological Associatio...
PDF
Mar 15, 2013
REDWOOD CITY, Calif. and ST. GALLEN, Switzerland, March 15, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the presentation of results from 22 studies at the 13th St. Gallen International Breast Cancer Conference highlighting the impact of the Oncotype DX® breast cancer test around the world.  New data continue to dem...
PDF
Mar 13, 2013
REDWOOD CITY, Calif., March 13, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results of a large study that demonstrates the Oncotype DX® Recurrence Score® result to be a robust predictor of loco-regional recurrence (LRR) in node-positive (N+), estrogen receptor (ER) positive patients treated with adjuv...
PDF
Feb 25, 2013
REDWOOD CITY, Calif., Feb. 25, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the results of two studies demonstrating that DNA strand-of-origin information can help further refine the identification of prognostic biomarkers, and that tumor specific gene mutations can be effectively examined using archival fixed paraffin e...
PDF
Feb 6, 2013
REDWOOD CITY, Calif., Feb. 6, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter and year ended December 31, 2012. Total revenue for the fourth quarter of 2012 increased to $60.4 million, compared with $53.4 million in the fourth quarter of 2011.  Product revenue wa...
PDF
Jan 30, 2013
REDWOOD CITY, Calif., Jan. 30, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Wednesday, February 6 at 4:30 p.m. Eastern Time to discuss its fourth quarter and year-end 2012 financial results.  The call and webcast will follow the release of the fourth quarter fin...
PDF
Jan 23, 2013
REDWOOD CITY, Calif., Jan. 23, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from three studies of the Oncotype DX® Colon Cancer test  at the 2013 Gastrointestinal (GI) Cancers Symposium, including new data demonstrating that Recurrence Score® (RS) results changed treatment recommendations in 45 percent ...
PDF
Dec 21, 2012
REDWOOD CITY, Calif., Dec. 21, 2012 /PRNewswire/ -- Genomic Health, Inc.  (Nasdaq: GHDX) today announced that Kim Popovits, Genomic Health's Chairman, Chief Executive Officer, and President will present at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 7 at 1:30 p.m. Pacific Time (PT).  To access the l...
PDF
Dec 10, 2012
REDWOOD CITY, Calif., Dec. 10, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the results from six studies of the Oncotype® DX breast cancer test presented at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) reinforcing the impact of the test on facilitating better informed treatment decisions in ...
PDF
Nov 28, 2012
REDWOOD CITY, Calif., Nov. 28, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from six Oncotype® DX breast cancer test studies at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), taking place December 6-8, 2012 at the Henry B. Gonzalez Convention Center.  Pre...
PDF
Nov 9, 2012
REDWOOD CITY, Calif., Nov. 9, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Genomic Health's Chief Executive Officer, Chairman and President will present at the following conferences in November: Credit Suisse 2012 Healthcare Conference on Thursday, November 15, 2012 at 2:00 p.m. Mountain Tim...
PDF
Nov 7, 2012
REDWOOD CITY, Calif., Nov. 7, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended September 30, 2012. Total revenue increased to $58.6 million in the third quarter of 2012, compared with $52.1 million in the third quarter of 2011, an increase of 13 percent.  Pr...
PDF
Oct 31, 2012
REDWOOD CITY, Calif, Oct. 31, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Wednesday, November 7 at 4:30 p.m. Eastern Time to discuss its third quarter 2012 financial results. The call and webcast will follow the release of the third quarter financial results af...
PDF
Sep 28, 2012
REDWOOD CITY, Calif., and VIENNA, Sept. 28, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the presentation of data that support expanded use of the Oncotype DX® tests in optimizing treatment decisions for breast and colon cancer patients at various stages of disease.  The new data confirm the ability of the Oncotype ...
PDF
Sep 18, 2012
REDWOOD CITY, Calif., Sept. 18, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results from a large clinical validation study of its biopsy-based prostate cancer test.  The study, performed in collaboration with leading prostate cancer researchers at the University of California, San Francisco (UCSF), met its prim...
PDF
Sep 13, 2012
SAN FRANCISCO, Sept. 13, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results of a large study that demonstrates the Oncotype DX® Recurrence Score® result to be a robust predictor of distant recurrence, disease-free survival, and overall survival in women with node-positive breast cancer who were treat...
PDF
Aug 8, 2012
REDWOOD CITY, Calif., Aug. 8, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended June 30, 2012.  Total revenue increased to $57.6 million in the second quarter of 2012, compared with $50.8 million in 2011, an increase of 13 percent.  Product revenue was $57.2...
PDF
Aug 7, 2012
REDWOOD CITY, Calif., Aug. 7, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the Company will present at the 32nd Annual Canaccord Genuity Growth Conference in Boston on Tuesday, August 14, 2012 at 2:00 p.m. Eastern Time (ET).  To access the live and subsequently archived webcast of the presentation, visit the...
PDF
Aug 1, 2012
REDWOOD CITY, Calif., Aug. 1, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Wednesday, August 8 at 4:30 p.m. Eastern Time to discuss its second quarter 2012 financial results. The call and webcast will follow the release of the second quarter financial results af...
PDF
Jul 25, 2012
REDWOOD CITY, Calif., July 25, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the peer-reviewed journal PLoS ONE published positive results from its groundbreaking clinical outcomes study for biomarker discovery applying Next Generation Sequencing (NGS) for whole transcriptome profiling of archival formalin-fixed para...
PDF
Jul 9, 2012
TORONTO, July 9, 2012 (GLOBE NEWSWIRE) -- Genomic Health, Inc. (Nasdaq:GHDX) today has released the results of the first Oncotype DX breast cancer test treatment decision-impact study from Canada, recently presented at the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting. Conducted at the BC Cancer Agency's Vancouver Centre and Sind...
PDF
Jun 1, 2012
REDWOOD CITY, Calif., June 1, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of 18 studies being presented at the American Society for Clinical Oncology® (ASCO®) Annual Meeting taking place June 1-5 in Chicago, Illinois.  New data includes validation of the Oncotype DX® colon cancer test in both stag...
PDF
May 29, 2012
REDWOOD CITY, Calif., May 29, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that members of its management team will present at the following conferences in June: Kim Popovits, Genomic Health's Chairman, Chief Executive Officer and President, will present at the Jefferies 2012 Global Healthcare Conference on Tu...
PDF
May 16, 2012
REDWOOD CITY, Calif., May 16, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from 18 separate studies covering breast, colon and prostate cancers will be presented at the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting, reflecting the company's ongoing commitment to the research, development a...
PDF
May 8, 2012
REDWOOD CITY, Calif., May 8, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Brad Cole, Genomic Health's Chief Operating Officer, will present the 11th Annual JMP Securities Research Conference in San Francisco on Tuesday, May 15 at 10:30 a.m. Pacific Time (PT).  To access the live and subsequently archived web...
PDF
May 2, 2012
REDWOOD CITY, Calif., May 2, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) and OncoMed Pharmaceuticals, Inc. (OncoMed) today announced a strategic alliance to use Next Generation Sequencing (NGS) to identify biomarkers that can be applied to the clinical development of OncoMed's  novel antibody cancer therapeutics. Under the terms...
PDF
May 2, 2012
REDWOOD CITY, Calif., May 2, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended March 31, 2012.  Total revenue increased to $58.5 million in the first quarter of 2012, compared with $49.8 million in 2011, an increase of 17 percent.  Product revenue was $57.9 m...
PDF
Apr 25, 2012
REDWOOD CITY, Calif., April 25, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Wednesday, May 2 at 4:30 p.m. Eastern Time to discuss its first quarter 2012 financial results. The call and webcast will follow the release of the first quarter financial results after...
PDF
Mar 21, 2012
GENEVA, March 21, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of three new Oncotype DX® studies including data demonstrating the test's cost-effectiveness within the German and Hungarian healthcare systems, and Israeli data showing the test's impact on treatment decisions in early-stage invasive breast canc...
PDF
Feb 6, 2012
REDWOOD CITY, Calif., Feb. 6, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced plans to establish a wholly owned subsidiary with the goal of improving the quality of diagnosis, communication and support for millions of patients and their families faced with common and rare genetic conditions.   The subsidiary is expected to ...
PDF
Feb 6, 2012
REDWOOD CITY, Calif., Feb. 6, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the year ended December 31, 2011.   Total revenue for the year ended December 31, 2011 increased to $206.1 million, compared with $178.1 million in 2010, an increase of 16 percent.  Product revenue was...
PDF
Feb 3, 2012
REDWOOD CITY, Calif., Feb. 3, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from a large clinical study in prostate cancer evaluating the relationship of microRNAs, a novel class of biomarkers, to clinical outcomes for patients with early-stage prostate cancer. The data, presented at the 2012 Genitourinary (GU) Ca...
PDF
Jan 30, 2012
REDWOOD CITY, Calif., Jan. 30, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Monday, February 6 at 4:30 p.m. Eastern Time to discuss its fourth quarter and year-end 2011 financial results. The call and webcast will follow the release of the fourth quarter financi...
PDF
Jan 20, 2012
REDWOOD CITY, Calif., Jan. 20, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results of the first clinical decision making study of the Oncotype DX® colon cancer test that shows that Recurrence Score® (RS) result has a significant impact on treatment recommendations for stage II colon cancer patients.  ...
PDF
Jan 9, 2012
REDWOOD CITY, Calif., Jan. 9, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that it has started a large clinical validation study of its prostate cancer test.  The study, being performed in collaboration with leading prostate cancer researchers at the University of California, San Francisco (UCSF), is designed to determin...
PDF
Jan 3, 2012
REDWOOD CITY, Calif., Jan. 3, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Genomic Health's President and Chief Executive Officer, will present at the 30th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 9 at 9:30 a.m. Pacific Time (PT).   To access the live and subseque...
PDF
Dec 12, 2011
REDWOOD CITY, Calif., Dec. 12, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the presentation of results from fourteen studies at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) reinforcing the impact of the Oncotype DX® breast cancer test on changing treatment decisions and demonstrating its cost effe...
PDF
Dec 8, 2011
SAN ANTONIO, Dec. 8, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the presentation of the first-of-its-kind clinical outcomes study for biomarker discovery applying next generation sequencing (NGS) for whole transcriptome profiling of archival formalin-fixed paraffin embedded (FFPE) tumor specimens.  Results presented at...
PDF
Dec 6, 2011
SAN ANTONIO, Dec. 6, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results from a clinical validation study of Oncotype DX® in patients with DCIS (ductal carcinoma in situ of the breast) conducted by the Eastern Cooperative Oncology Group (ECOG), a clinical trials cooperative group supported by the National ...
PDF
Nov 29, 2011
REDWOOD CITY, Calif., Nov. 29, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from sixteen studies at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), taking place December 6-10, 2011 at the Henry B. Gonzalez Convention Center.  The SABCS press briefing on Wednesday, Dec...
PDF
Nov 22, 2011
REDWOOD CITY, Calif., Nov. 22, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Genomic Health's Executive Chairman of the Board, will present at the Piper Jaffray Health Care Conference in New York City on Tuesday, November 29, 2011 at 1:30 p.m. Eastern Time (ET).   To access the live and subsequently a...
PDF
Nov 8, 2011
REDWOOD CITY, Calif., Nov. 8, 2011 /PRNewswire/ -- Genomic Health, Inc. today announced that the Journal of Clinical Oncology (JCO) published positive results from the landmark QUASAR clinical validation study, which demonstrated that the Oncotype DX® colon cancer test predicts recurrence risk in stage II colon cancer patients following surger...
PDF
Nov 1, 2011
REDWOOD CITY, Calif., Nov. 1, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended September 30, 2011. Total revenue increased to $52.1 million in the third quarter of 2011, compared with $46.3 million in the third quarter of 2010.  Product revenue was $51.7 million...
PDF
Oct 25, 2011
REDWOOD CITY, Calif., Oct. 25, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, November 1 at 4:30 p.m. Eastern Time to discuss its third quarter 2011 financial results.  The call and webcast will follow the release of the third quarter financial results af...
PDF
Oct 25, 2011
REDWOOD CITY, Calif., Oct. 25, 2011 /PRNewswire/ -- Genomic Health, Inc., (Nasdaq: GHDX) today launched a smartphone application designed to help people who are newly diagnosed with breast cancer or colon cancer to better access and manage information important for their personalized treatment plan. The application was developed in partnership with...
PDF
Sep 30, 2011
REDWOOD CITY, Calif., Sept. 30, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Palmetto GBA, the designated national contractor for its Oncotype DX® colon cancer test, has established a formal coverage policy for all Medicare patients.  The Oncotype DX colon cancer test has been clinically validated to predict ri...
PDF
Sep 21, 2011
REDWOOD CITY, Calif., Sept. 21, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Dean Schorno, Genomic Health's Chief Financial Officer, will present at the JMP Securities Healthcare Conference in New York City on Tuesday, September 27, 2011 at 3:00 p.m. Eastern Time (ET).   To access the live and subsequently archiv...
PDF
Sep 13, 2011
REDWOOD CITY, Calif., Sept. 13, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of five studies covering breast and colon cancers that will be presented during poster sessions at the 2011 European Multidisciplinary Cancer Congress, September 23-27, in Stockholm, Sweden. Breast cancer presentations include health ...
PDF
Aug 4, 2011
REDWOOD CITY, Calif., Aug. 4, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Dean Schorno, Genomic Health's Chief Financial Officer, will present at the 31st Annual Canaccord Genuity Growth Conference in Boston on Thursday, August 11, 2011 at 11:30 a.m. Eastern Time (ET).   To access the live and subsequently archi...
PDF
Aug 3, 2011
REDWOOD CITY, Calif., Aug. 3, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended June 30, 2011. Total revenue increased to $50.8 million in the second quarter of 2011, compared with $43.4 million in the second quarter of 2010.  Product revenue was $50.5 million in...
PDF
Jul 27, 2011
REDWOOD CITY, Calif., July 27, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Wednesday, August 3 at 4:30 p.m. Eastern Time to discuss its second quarter 2011 financial results.  The call and webcast will follow the release of the second quarter financial results ...
PDF
Jul 25, 2011
GENEVA, SWITZERLAND and REDWOOD CITY, CA -- (MARKET WIRE) -- 07/25/11 -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that the 12th St. Gallen International Breast Cancer Conference (2011) Expert Panel distinguishes Oncotype DX® as the multi-gene expression test that predicts chemotherapy benefit in patients with estrogen receptor-...
PDF
Jun 4, 2011
CHICAGO, June 4, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of ten studies being presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, including a second large validation study confirming the performance of the Oncotype DX® colon cancer Recurrence Score® (RS) as an independent ...
PDF
May 27, 2011
REDWOOD CITY, Calif., May 27, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that members of its management team will present at the following conferences in June: Brad Cole, Genomic Health's Chief Operating Officer, will present at the Jefferies 2011 Global Healthcare Conference on Monday, June 6 at 3:30 p.m. ET in New...
PDF
May 24, 2011
REDWOOD CITY, Calif., May 24, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive preliminary results from a study of Oncotype DX® in patients with DCIS (ductal carcinoma in situ of the breast) conducted by the Eastern Cooperative Oncology Group (ECOG), a clinical trials cooperative group supported by the National...
PDF
May 18, 2011
REDWOOD CITY, Calif., May 18, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from ten separate studies at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place June 3-7, 2011 at McCormick Place in Chicago.  The company markets the widely-adopted Oncotype DX®...
PDF
May 3, 2011
REDWOOD CITY, Calif., May 3, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended March 31, 2011. Total revenue increased to $49.8 million in the first quarter of 2011, compared with $41.2 million in the first quarter of 2010.  Product revenue was $49.5 million in t...
PDF
Apr 26, 2011
REDWOOD CITY, Calif., April 26, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the launch of RxPONDER S1007 (Rx for Positive Node, Endocrine Responsive Breast Cancer), a clinical trial being led by SWOG, one of the largest National Cancer Institute (NCI) supported cancer cooperative groups.  The trial is designed to determ...
PDF
Apr 25, 2011
REDWOOD CITY, Calif., April 25, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, May 3 at 4:30 p.m. Eastern Time to discuss its first quarter 2011 financial results.  The call and webcast will follow the release of the first quarter financial results after ...
PDF
Mar 17, 2011
REDWOOD CITY, Calif. and ST. GALLEN, Switzerland, March 17, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from nine studies utilizing the Oncotype DX® test in early-stage breast cancer patients at the 12th Annual St. Gallen International Breast Cancer Conference in St. Gallen, Switzerland.  The studies includ...
PDF
Mar 9, 2011
REDWOOD CITY, CA -- (MARKET WIRE) -- 03/09/11 -- Genomic Health, Inc. (NASDAQ: GHDX), in partnership with Fight Colorectal Cancer, today introduced My Colon Cancer Coach, a unique online tool that provides patients with a personalized report of their specific type of colon cancer. Coach empowers patients with individualized information based o...
PDF
Feb 24, 2011
REDWOOD CITY, Calif., Feb. 24, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Brad Cole, Chief Operating Officer of Genomic Health, will provide a corporate update during the 2011 RBC Capital Markets' Healthcare Conference in New York on Wednesday, March 2, 2011 at 10:30 a.m. Eastern Time (ET).  Additionally, Kim Popo...
PDF
Feb 15, 2011
REDWOOD CITY, Calif., Feb. 15, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the presentation of two studies at the American Society of Clinical Oncology® (ASCO®)(1)) Genitourinary (GU) Cancer Symposium, including complete results from its prostate cancer gene identification study, which identified 295 genes strongly asso...
PDF
Feb 8, 2011
REDWOOD CITY, Calif., Feb. 8, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended December 31, 2010. Total revenue for the year ended December 31, 2010 increased to $178.1 million, compared with $149.5 million in 2009, an increase of 19 percent.  Product revenue wa...
PDF
Feb 3, 2011
REDWOOD CITY, Calif., Feb. 3, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that its scientists successfully surveyed expression of the whole human transcriptome using next-generation DNA sequencing technology developed by Illumina, Inc., to test hypotheses for biomarker discovery in archived tumor and normal breast tissu...
PDF
Jan 27, 2011
REDWOOD CITY, Calif., Jan. 27, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, February 8 at 4:30 p.m. Eastern Time to discuss its fourth quarter and year-end 2010 financial results.  The call and webcast will follow the release of the fourth quarter finan...
PDF
Jan 21, 2011
REDWOOD CITY, Calif., Jan. 21, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced presentation of three studies at the American Society of Clinical Oncology® (ASCO®) (1) Gastrointestinal (GI) Cancer Symposium, including one finding that high tumor grade was not a marker of higher recurrence risk in stage II colon cancer, sugge...
PDF
Jan 10, 2011
REDWOOD CITY, Calif., Jan. 10, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced it will accelerate its prostate cancer clinical development program with the goal of launching a test globally in 2013, previously planned for launch in 2014, in light of positive top-line results of a large gene identification study which were p...
PDF
Jan 4, 2011
REDWOOD CITY, Calif., Jan. 4, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Genomic Health's President and Chief Executive Officer, will present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 10 at 3:30 p.m. Pacific Time. To access the live and subsequently a...
PDF
Dec 13, 2010
SAN ANTONIO, Dec. 13, 2010 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from seven new studies focusing on its multigene Oncotype DX® breast cancer test, which has helped guide treatment decisions in more than 175,000 breast cancer patients worldwide.  The data, presented this past week at the 33rd Annual CTRC-AACR Sa...
PDF
Dec 9, 2010
REDWOOD CITY, Calif., Dec. 9, 2010 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the first results of a large prostate cancer study that identified 295 genes strongly associated with clinical recurrence following radical prostatectomy.  Top-line findings from this study, which applied the same RT-PCR technology used in Genomic...
PDF
Dec 3, 2010
REDWOOD CITY, Calif., Dec. 3, 2010 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from seven studies at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), taking place December 8-12, 2010 at the Henry B. Gonzalez Convention Center.  All of the studies analyze the company...
PDF
Nov 12, 2010
REDWOOD CITY, CA -- (MARKET WIRE) -- 11/12/10 -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that members of its management team will present at the following conferences in November: Brad Cole, Genomic Health's Chief Operating Officer and Chief Financial Officer, will present at the Stephens Fall Investment Conference 2...
PDF
Nov 8, 2010
REDWOOD CITY, Calif., Nov. 8, 2010 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended September 30, 2010. Total revenue increased to $46.3 million in the third quarter of 2010, compared with $39.5 million in the third quarter of 2009.  Product revenue was $45...
PDF
Oct 26, 2010
REDWOOD CITY, Calif., Oct 26, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Monday, November 8 at 4:30 p.m. Eastern Time to discuss its third quarter 2010 financial results. The call and webcast will follow the release of the third quarter...
PDF
Oct 11, 2010
REDWOOD CITY, CA, Oct 11, 2010 (MARKETWIRE via COMTEX News Network) -- Genomic Health, Inc. (NASDAQ: GHDX) today announced positive results from a prospective, multi-center, study that showed the Oncotype DX(R) Recurrence Score(R) (RS) result had a significant impact on treatment decisions for early-stage breast cancer patients in Spain. The study ...
PDF
Oct 4, 2010
REDWOOD CITY, CA, Oct 04, 2010 (MARKETWIRE via COMTEX News Network) -- Genomic Health, Inc. (NASDAQ: GHDX) today announced the launch of an online campaign, Pass It On... Until Every Woman Knows, to educate people about personalized breast cancer treatment and the Oncotype DX(R) breast cancer test. The campaign uses online sharing tools and social ...
PDF
Sep 13, 2010
REDWOOD CITY, Calif., Sept 13, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that members of its management team will present at the following conferences in September: Dean Schorno, senior vice president of Finance, will present at the Stifel Nicolaus Healthcare Conference 2010 on Friday, Septemb...
PDF
Aug 4, 2010
REDWOOD CITY, Calif., Aug 04, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended June 30, 2010. Total revenue increased to $43.4 million in the second quarter of 2010 compared with $36.6 million in the second quarter of 2009. Product revenue...
PDF
Jul 28, 2010
REDWOOD CITY, Calif., July 28, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Wednesday, August 4 at 4:30 p.m. Eastern Time to discuss its second quarter 2010 financial results. The call and webcast will follow the release of the second qua...
PDF
Jun 5, 2010
CHICAGO, June 5, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the results of six studies being presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, including an evaluation of biological similarities and differences between stage II and III colon cancer, suggesting a potent...
PDF
Jun 4, 2010
CHICAGO, June 4, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the first results from its collaboration with Pfizer Oncology to study early-stage renal cell carcinoma prognosis, which demonstrated a strong correlation between gene expression and recurrence risk in this patient population. The stud...
PDF
Jun 2, 2010
REDWOOD CITY, Calif., June 2, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that members of its management team will present at the following conferences in June: Brad Cole, Genomic Health's Chief Operating Officer and Chief Financial Officer, will present at the Jefferies 2010 Global Life Science...
PDF
May 20, 2010
REDWOOD CITY, Calif., May 20, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from six separate studies at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place June 4-8, 2010 at McCormick Place in Chicago. The studies include four oral p...
PDF
May 19, 2010
REDWOOD CITY, Calif., May 19, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Genomic Health's President and Chief Executive Officer, will present at the 2010 Citi Investment Research Global Health Care Conference in New York City on Wednesday, May 26 at 3:30 p.m. ET. To access th...
PDF
May 5, 2010
REDWOOD CITY, Calif., May 5, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended March 31, 2010. Total revenue increased to $41.2 million in the first quarter of 2010 compared with $33.9 million in the first quarter of 2009. Product revenue f...
PDF
May 3, 2010
REDWOOD CITY, CA, May 03, 2010 (MARKETWIRE via COMTEX News Network) -- Genomic Health, Inc. (NASDAQ: GHDX) today announced results from a study which found that results of the Oncotype DX(R) breast cancer test are available sooner in the treatment decision making process when breast surgeons order the test. The study, presented last week at the Ame...
PDF
May 3, 2010
REDWOOD CITY, Calif., May 3, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Genomic Health's Chief Executive Officer, will present at the Ninth Annual JMP Securities Research Conference in San Francisco on Monday, May 10 at 10:30 a.m. PT. To access the live and subsequently archi...
PDF
Apr 28, 2010
REDWOOD CITY, Calif., April 28, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Wednesday, May 5 at 4:30 p.m. Eastern Time to discuss its first quarter 2010 financial results. The call and webcast will follow the release of the first quarter...
PDF
Mar 25, 2010
REDWOOD CITY, Calif. and BARCELONA, March 25, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company has entered into an exclusive agreement with Palex Medical S.A., one of Europe's leading distributors of medical device and diagnostic services to hospitals, to distribute its Oncotype DX(R)...
PDF
Mar 8, 2010
REDWOOD CITY, Calif., March 8, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the publication of positive results from a large international study which demonstrated that the Oncotype DX(R) breast cancer Recurrence Score(R) (RS) result is a significant independent predictor of distant recurrence in ...
PDF
Mar 1, 2010
REDWOOD CITY, Calif., March 1, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that its research scientists have developed a clinically useful method for whole genome expression analysis using standard tumor specimens that are routinely collected in clinical practice. Genomic Health is now able to a...
PDF
Feb 26, 2010
REDWOOD CITY, CA and KYOTO, JAPAN, Feb 26, 2010 (MARKETWIRE via COMTEX News Network) -- Genomic Health, Inc. (NASDAQ: GHDX) today announced results from an analysis demonstrating that the Oncotype DX(R) breast cancer test has similar clinical relevance in estrogen receptor-positive, early-stage breast cancer patients in Asia Pacific (AP) countries ...
PDF
Feb 3, 2010
REDWOOD CITY, Calif., Feb 03, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results for the year ended December 31, 2009, which included 35 percent revenue growth compared with 2008, and the company becoming cash flow positive. Total revenue for the fourth quarter of 2009 increased to $3...
PDF
Jan 27, 2010
REDWOOD CITY, Calif., Jan 27, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Wednesday, February 3 at 4:30 p.m. Eastern Time to discuss its fourth quarter and year-end 2009 financial results. The call and webcast will follow the release of...
PDF
Jan 21, 2010
REDWOOD CITY, Calif., Jan 21, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced worldwide commercial availability of its Oncotype DX(R) colon cancer test, the first multigene expression test developed for the assessment of risk of recurrence in patients with stage II disease. The 12-gene advanced dia...
PDF
Jan 12, 2010
REDWOOD CITY, Calif., Jan 12, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the publication of a prospective, multi-center, study that showed the Oncotype DX(R) breast cancer test Recurrence Score(R) had a significant impact on breast cancer treatment decisions for early-stage breast cancer patient...
PDF
Jan 7, 2010
REDWOOD CITY, Calif., Jan 07, 2010 /PRNewswire via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that it expects to meet its 2009 annual revenue guidance. Preliminary total revenue for the year ended December 31, 2009 is expected to be $149.5 million, compared with $110.6 million in 2008, representing an increase of ...
PDF
Jan 4, 2010
REDWOOD CITY, Calif., Jan 04, 2010 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Genomic Health's Chief Executive Officer, will present at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 11 at 4 p.m. Pacific Time. To access the live and...
PDF
Dec 15, 2009
REDWOOD CITY, CA, Dec 15, 2009 (MARKETWIRE via COMTEX News Network) -- Genomic Health, Inc. (NASDAQ: GHDX) today announced results from five new studies on its Oncotype DX(R) breast cancer test, a multi-gene expression test that physicians currently use to predict the likelihood of chemotherapy benefit and recurrence risk for patients with early-st...
PDF
Dec 11, 2009
SAN ANTONIO, Dec 11, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from a clinical survey evaluating the impact of the Oncotype DX(R) Recurrence Score(R) result on physicians' adjuvant treatment recommendations for patients with node-positive, hormone receptor-positive breast canc...
PDF
Dec 10, 2009
SAN ANTONIO, Dec 10, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that The Lancet Oncology published positive results from a study of Oncotype DX((R)) in postmenopausal women with node-positive, estrogen receptor-positive breast cancer conducted by the Southwest Oncology Group (SWOG), a ...
PDF
Dec 4, 2009
REDWOOD CITY, Calif., Dec 04, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from five studies at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS), taking place December 9-13, 2009, at the Henry B. Gonzalez Convention Center. Four of the st...
PDF
Nov 24, 2009
REDWOOD CITY, Calif., Nov 24, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Genomic Health's Executive Chairman, will present at the 21st Annual Piper Jaffray Health Care Conference in New York City on Tuesday, December 1, 2009 at 10:00 a.m. ET. To access the live and s...
PDF
Nov 4, 2009
REDWOOD CITY, Calif., Nov 04, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended September 30, 2009. Total revenue increased to $39.5 million in the third quarter of 2009 compared with $28.1 million in the third quarter of 2008. Pr...
PDF
Oct 28, 2009
REDWOOD CITY, Calif., Oct 28, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Wednesday, November 4, 2009 at 4:30 p.m. Eastern Time (ET) to discuss its third quarter 2009 financial results. The call and webcast will follow the rele...
PDF
Oct 23, 2009
SAN FRANCISCO, Oct 23, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health (Nasdaq: GHDX) today announced that the Company will hold a business and scientific briefing on Thursday, November 12, 2009 beginning at 12:30 p.m. ET in New York City. Members of Genomic Health's management team will discuss how the company is breaking ba...
PDF
Oct 9, 2009
SAN FRANCISCO, Oct 09, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from a study demonstrating the critical role of manual microdissection to remove all biopsy cavities from breast cancer specimens. Genomic Health's Oncotype DX is the only commercially available breast cancer te...
PDF
Oct 8, 2009
REDWOOD CITY, CA - October 8, 2009 - Breastcancer.org has joined with Genomic Health, Inc. and Breast Cancer Network of Strength to expand My Breast Cancer Coach, a uni...
PDF
Oct 6, 2009
REDWOOD CITY, Calif., Oct 06, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from two studies at the American Society of Clinical Oncology (ASCO) 2009 Breast Cancer Symposium, taking place October 8 through October 10 at the San Francisco Marriott in S...
PDF
Sep 30, 2009
REDWOOD CITY, Calif., Sept 30, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Brad Cole, Genomic Health's Chief Operating Officer and Chief Financial Officer, will present at the JMP Securities Healthcare Focus Conference in New York City, on Tuesday, October 6 at 9:30 a.m. ET. To ac...
PDF
Sep 22, 2009
BERLIN, Sep 22, 2009 (MARKETWIRE via COMTEX News Network) -- Genomic Health, Inc. (NASDAQ: GHDX) today, announced results from the first study to compare the distribution of Oncotype DX(R) Recurrence Score(R) results between European, Middle Eastern and United States patient populations. The findings (Abstract 194), confirming that the distribution...
PDF
Sep 3, 2009
REDWOOD CITY, CA, Sep 03, 2009 (MARKETWIRE via COMTEX News Network) -- In an effort to provide breast cancer patients with prompt, critical information about treatment options for use at their first visit with the medical oncologist, a number of leading U.S. surgeons request Genomic Health's Oncotype DX molecular test at the time of surgery or biop...
PDF
Sep 3, 2009
REDWOOD CITY, Calif., Sept 03, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Executive Chairman, will present at the following conferences in September: -- Thomas Weisel Partners' Healthcare Conference on Wednesday, September 9, a...
PDF
Aug 6, 2009
REDWOOD CITY, Calif., Aug 06, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Genomic Health's Chief Executive Officer, will present at the Canaccord Adams 29th Annual Global Growth Conference in Boston, on Thursday, August 13 at 1:30 p.m. ET. To access the live and subs...
PDF
Aug 4, 2009
REDWOOD CITY, Calif., Aug 4, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended June 30, 2009. Total revenue increased to $36.6 million in the second quarter of 2009 compared with $27.8 million in the second quarter of 2008. Produc...
PDF
Jul 31, 2009
Redwood City, California July 31, 2009 - As a leader in the field of personalized medicine, Genomic Health Inc. (NASDAQ: GHDX), is now lending its perspective on important industry issues, via an online Op-Ed column titled "Our Perspective." The current article, "Our Perspective, Three Essential Compon...
PDF
Jul 28, 2009
REDWOOD CITY, Calif., July 28, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, August 4, 2009 at 4:30 p.m. Eastern Time to discuss its second quarter 2009 financial results. The call and webcast will follow the release of...
PDF
Jun 26, 2009
GENEVA, and REDWOOD CITY, Calif., June 26, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported that the St. Gallen International Consensus Panel on the Primary Therapy of Early Breast Cancer recommended for the first time that validated multigene assays, such as Oncotype DX(R), should be conside...
PDF
May 29, 2009
ORLANDO, Fla., May 29, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from a study which summarized the gene signatures identified by the Oncotype DX(R) breast cancer test in a large number of male patients for whom the test was used to guide treatment with chemotherapy. The result...
PDF
May 28, 2009
REDWOOD CITY, Calif., May 28, 2009 – Genomic Health, Inc. (Nasdaq: GHDX) today announced an important milestone in reaching a total of more than 100,000 patients with its Oncotype DX® breast cancer test since the test became available in 2004. Oncotype DX is the first and only gene expression test clinically validated to predict the likelihood...
PDF
May 21, 2009
REDWOOD CITY, Calif., May 21, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from three studies at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29 - June 2, 2009, at the Orange County Convention Center in Orlando, F...
PDF
May 14, 2009
REDWOOD CITY, Calif., May 14, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results from the landmark QUASAR validation study, which demonstrated that the Oncotype DX(R) colon cancer test can independently predict individual recurrence risk in stage II colon cancer patients follo...
PDF
May 13, 2009
REDWOOD CITY, Calif., May 13, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Brad Cole, Genomic Health's Chief Operating and Financial Officer, will present at the Eighth Annual JMP Securities Research Conference in San Francisco, on Tuesday, May 19, 2009 at 11:00 a.m. PT. To access ...
PDF
May 5, 2009
REDWOOD CITY, Calif., May 5, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended March 31, 2009. Total revenue increased to $33.9 million in the first quarter of 2009 compared with $23.4 million in the first quarter of 2008. Product ...
PDF
Apr 28, 2009
REDWOOD CITY, Calif., April 28, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, May 5, 2009 at 4:30 p.m. Eastern Time to discuss its first quarter 2009 financial results. The call and webcast will follow the release of th...
PDF
Apr 20, 2009
REDWOOD CITY, Calif. and KYOTO, Japan, April 20, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of a multi-center Japanese study demonstrating that the Oncotype DX breast cancer assay had significant prognostic value in Japanese women with estrogen receptor-positive early-stage bre...
PDF
Apr 14, 2009
REDWOOD CITY, Calif., April 14, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the QUASAR validation study met its primary endpoint to predict the likelihood of recurrence for stage II colon cancer patients following surgery, and that the colon cancer Recurrence Score(R) provided add...
PDF
Feb 3, 2009
REDWOOD CITY, Calif., Feb 03, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the fourth quarter and year ended December 31, 2008. Total revenue for the fourth quarter of 2008 increased to $31.2 million, compared with $19.3 million in the fourt...
PDF
Jan 27, 2009
REDWOOD CITY, Calif., Jan 27, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, February 3, 2009 at 4:30 p.m. Eastern Time to discuss its fourth quarter and year-end 2008 financial results. The call and webcast will follow t...
PDF
Jan 12, 2009
REDWOOD CITY, Calif., Jan 12, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- - Company to Provide Update on Pipeline Efforts at 27th Annual J.P. Morgan Healthcare Conference - Genomic Health, Inc. (Nasdaq: GHDX) announced today that it has initiated an independent clinical validation study for its 18-gene Oncotype DX(R) colon cancer assay....
PDF
Jan 8, 2009
REDWOOD CITY, Calif., Jan 08, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the appointment of Kimberly J. Popovits as chief executive officer. Formerly president and chief operating officer, Popovits is now the president and CEO of Genomic Health. In addition, G. Bradley Cole has b...
PDF
Dec 13, 2008
SAN ANTONIO, Dec 13, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced findings from a European study demonstrating that the Oncotype DX Recurrence Score(R) result is a significant independent predictor of distant recurrence in both node-negative and node-positive, hormone receptor-positi...
PDF
Dec 8, 2008
REDWOOD CITY, Calif., Dec 08, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the appointment of Ginger L. Graham to its board of directors. Ms. Graham is the former President and CEO of Amylin Pharmaceuticals, Inc.; a biopharmaceutical company dedicated to developing innovative medici...
PDF
Dec 5, 2008
REDWOOD CITY, Calif., Dec 05, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from four studies at the 31st Annual San Antonio Breast Cancer Symposium, taking place December 10-14, 2008, at the Henry B. Gonzalez Convention Center. Two of the studie...
PDF
Nov 11, 2008
REDWOOD CITY, Calif., Nov 11, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will present at the Stephens Fall Investment Conference in New York on Tuesday, November 18, 2008 at 11:00 a.m. ET. To access the...
PDF
Nov 10, 2008
REDWOOD CITY, Calif., Nov 10, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the publication of results from a study indicating that Oncotype DX(R) Recurrence Score(R) results impact the way physicians treat early-stage breast cancer. The study, published in the October issue of the Americ...
PDF
Nov 5, 2008
REDWOOD CITY, Calif., Nov 05, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended September 30, 2008. Total revenue increased to $28.1 million in the third quarter of 2008 compared with $15.9 million in the third quarter of 2007. ...
PDF
Oct 29, 2008
REDWOOD CITY, Calif., Oct 29, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Wednesday, November 5, 2008 at 4:30 p.m. Eastern Time to discuss its third quarter 2008 financial results. The call and webcast will follow the release o...
PDF
Sep 30, 2008
REDWOOD CITY, Calif., Sept 30, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Genomic Health's President and Chief Operating Officer, will present at the JMP Securities Healthcare Focus Conference in New York on Tuesday, October 7, 2008 at 10:00 a.m. ET. To access th...
PDF
Sep 6, 2008
REDWOOD CITY, Calif., Sept 06, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from two studies demonstrating that quantitative reporting for HER2 gene expression, as measured by the company's Oncotype DX(R) breast cancer assay, has a high degree of concordance with both fluorescenc...
PDF
Sep 3, 2008
REDWOOD CITY, Calif., Sept 03, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the publication of positive results from a study indicating that the Oncotype DX(R) Recurrence Score(R) provides additional prognostic information beyond Adjuvant! Online (AO) for breast cancer patients with nega...
PDF
Aug 5, 2008
REDWOOD CITY, Calif., Aug 05, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended June 30, 2008. Total revenue increased to $27.8 million in the second quarter of 2008 compared to $14.7 million in the second quarter of 2007. Produ...
PDF
Jul 29, 2008
REDWOOD CITY, Calif., July 29, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, August 5, 2008 at 4:30 p.m. Eastern Time to discuss its second quarter 2008 financial results. The call and webcast will follow the release of ...
PDF
Jun 2, 2008
REDWOOD CITY, Calif., June 2, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the Journal of Clinical Oncology (JCO) published results of a study confirming RT-PCR by Oncotype DX can deliver quantitative gene expression levels for assessing estrogen receptor (ER) and progesterone recep...
PDF
May 31, 2008
REDWOOD CITY, Calif., May 31, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX), provider of the Oncotype DX(R) breast cancer assay, today announced results of two separate studies presented at the annual meeting of the American Society of Clinical Oncology (ASCO), that could lead to the development of new t...
PDF
May 8, 2008
REDWOOD CITY, Calif., May 8, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will present at the Bank of America 2008 Healthcare Conference in Las Vegas, NV on Wednesday, May 14, 2008 at 3:20 p.m. Pacific Time. ...
PDF
May 6, 2008
REDWOOD CITY, Calif., May 6, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended March 31, 2008. Total revenue increased to $23.4 million in the first quarter of 2008 compared to $14.1 million in the first quarter of 2007. Product...
PDF
Apr 29, 2008
REDWOOD CITY, Calif., April 29, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, May 6, 2008 at 4:30 p.m. Eastern Time to discuss its first quarter 2008 financial results. The call and webcast will follow the release of the...
PDF
Apr 28, 2008
REDWOOD CITY, Calif., April 28, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will present at the Morgan Stanley Global Healthcare Unplugged Conference in Key Biscayne, FL on May 2, 2008 at 8:30 a.m. Eastern T...
PDF
Mar 28, 2008
REDWOOD CITY, Calif., March 28, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Steven Shak, M.D., Genomic Health's Chief Medical Officer, will participate in Leerink Swann's Roundtable Conference, Bugs and Drugs: The Future of Molecular Diagnostics, in New York, NY on April 3, 2008 at...
PDF
Mar 12, 2008
REDWOOD CITY, Calif., March 12, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will present at the Lehman Brothers Eleventh Annual Global Healthcare Conference in Miami, FL on March 19, 2008 at 5:15 p.m. Easter...
PDF
Feb 8, 2008
REDWOOD CITY, Calif., Feb 08, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Genomic Health's President and Chief Operations Officer, will present at the BIO CEO & Investor Conference in New York, NY on Feb. 12, 2008 at 10:15 a.m. Eastern Time. To access the live and...
PDF
Feb 5, 2008
REDWOOD CITY, Calif., Feb 05, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the fourth quarter and year ended December 31, 2007. Total revenue increased to $19.3 million in the fourth quarter of 2007 compared to $8.6 million in the fourth qua...
PDF
Jan 30, 2008
REDWOOD CITY, Calif., Jan 30, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, February 5, 2008 at 4:30 p.m. Eastern Time to discuss its fourth quarter and year end 2007 financial results. The call and webcast will follow t...
PDF
Jan 28, 2008
REDWOOD CITY, Calif., Jan 28, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the results of studies that have identified genes that could help predict the likelihood of recurrence and chemotherapy benefit for early-stage (stage II and III) colon cancer. The company is conducting detailed a...
PDF
Jan 7, 2008
REDWOOD CITY, Calif., Jan 07, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) announced today a collaboration with Pfizer on the development of a genomic test to estimate the risk of recurrence following surgery for patients with Stage I-III renal carcinoma, clear cell type, that has not spread to other pa...
PDF
Jan 3, 2008
REDWOOD CITY, Calif., Jan 03, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will present at the 26th Annual JPMorgan Healthcare Conference in San Francisco, CA on Wednesday, January 9 at 9 a.m. Pacific Time. ...
PDF
Jan 2, 2008
REDWOOD CITY, Calif., Jan 02, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported that the company's Oncotype DX(R) breast cancer assay, used to predict the likelihood of disease recurrence and the likelihood of chemotherapy benefit for a large portion of early-stage breast cancer patients, has ...
PDF
Dec 17, 2007
REDWOOD CITY, Calif., Dec 17, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from multiple studies reinforcing the clinical utility of the company's Oncotype DX(R), a multi-gene expression test to predict the likelihood of recurrence and the likelihood of chemotherapy benefit for a...
PDF
Dec 15, 2007
SAN ANTONIO, Dec 15, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results from a study showing that the Oncotype DX Recurrence Score(TM) provides additional prognostic information in patients with early-stage breast cancer beyond that derived from Adjuvant Online, an online tool...
PDF
Dec 7, 2007
REDWOOD CITY, Calif., Dec 07, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from eight studies of the company's Oncotype DX(R) breast cancer test are scheduled to be presented at the 30th Annual San Antonio Breast Cancer Symposium, taking place December 13-16, 2007. Oncotype ...
PDF
Nov 21, 2007
REDWOOD CITY, Calif., Nov 21, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will present at the Piper Jaffray Health Care Conference in New York, NY on November 28, 2007 at 1:00 p.m. Eastern Time. To acces...
PDF
Nov 7, 2007
REDWOOD CITY, Calif., Nov 07, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Genomic Health's President and Chief Operating Officer, will present at the JMP Securities Healthcare Focus Conference in Boston, MA on November 13, 2007 at 2:30 p.m. Eastern Time. To access...
PDF
Nov 2, 2007
REDWOOD CITY, Calif., Nov 02, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Genomic Health's President and Chief Operating Officer, will present at JPMorgan's Ninth Annual SMid-Cap Conference in Boston, MA on November 5, 2007 at 2:05 p.m. Eastern Time. To access the...
PDF
Oct 30, 2007
REDWOOD CITY, Calif., Oct 30, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the third quarter ended September 30, 2007. Total revenue increased to $15.9 million in the third quarter of 2007 compared to $7.1 million in the third quarter of 200...
PDF
Oct 24, 2007
REDWOOD CITY, Calif., Oct 24, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, October 30, 2007 at 4:30 p.m. Eastern Time to discuss its third quarter 2007 financial results. The call and webcast will follow the release of ...
PDF
Oct 22, 2007
REDWOOD CITY, Calif., Oct 22, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported that the company's Oncotype DX(TM) breast cancer assay, used to predict the likelihood of disease recurrence and likelihood of chemotherapy benefit for node-negative, estrogen receptor-positive breast cancer patien...
PDF
Oct 11, 2007
REDWOOD CITY, Calif., Oct 11, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced encouraging results from a study of Oncotype DX in postmenopausal women with node-positive, hormone receptor positive breast cancer conducted by the Southwest Oncology Group (SWOG), a National Cancer Institute cli...
PDF
Oct 4, 2007
REDWOOD CITY, Calif., Oct 04, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will present at the BIO InvestorForum 2007 in San Francisco, CA on October 11, 2007 at 3:00 p.m. Pacific Time. To access the live...
PDF
Sep 17, 2007
REDWOOD CITY, Calif., Sept 17, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will present at the ThinkEquity Partners Fifth Annual Growth Conference in San Francisco, CA on September 18, 2007 at 8:00 a.m. Paci...
PDF
Sep 10, 2007
REDWOOD CITY, Calif., Sept 10, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from three studies that support the use of quantitative real-time polymerase chain reaction (RT-PCR), as performed in the Oncotype DX assay, for measuring the hormone receptors, estrogen receptor (ER) and...
PDF
Aug 6, 2007
REDWOOD CITY, Calif., Aug 06, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the second quarter ended June 30, 2007. Total revenue increased to $14.7 million in the second quarter of 2007 compared to $8.4 million in the second quarter of 2006....
PDF
Jul 30, 2007
REDWOOD CITY, Calif., July 30, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Monday, August 6, 2007 at 4:30 p.m. Eastern Time to discuss its second quarter 2007 financial results. The call and webcast will follow the release of t...
PDF
Jul 18, 2007
REDWOOD CITY, Calif., July 18, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that during the Blue Cross and Blue Shield Association Medical Advisory Panel meeting on June 28, 2007, the panel concluded that use of Genomic Health's Oncotype DX breast cancer assay to inform decision mak...
PDF
Jun 3, 2007
CHICAGO, June 3, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results of a first study analyzing patient samples from a large trial conducted by the Eastern Cooperative Oncology Group (ECOG), a National Cancer Institute clinical trials cooperative group, in patients with node ne...
PDF
Jun 2, 2007
CHICAGO, June 2, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of an independent prospective multi-center study indicating that the Oncotype DX Recurrence Score changes treatment decisions and increases confidence for a high proportion of patients with early-stage node-negative, e...
PDF
Jun 1, 2007
REDWOOD CITY, Calif., June 1, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company signed an exclusive agreement with Medical Solutions plc (LSE: MLS), a healthcare and diagnostics business specializing in diagnostic pathology and cytology services and products, to distribute th...
PDF
May 29, 2007
REDWOOD CITY, Calif., May 29, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced two posters to be presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) taking place in Chicago, IL, from June 1 - 5, 2007. Following are details for each embargoed session: ...
PDF
May 21, 2007
REDWOOD CITY, Calif., May 21, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the pricing of the underwritten public offering of 3,000,000 shares of its common stock at a price to the public of $15.50 per share. All of the shares are being offered by Genomic Health. J.P. Morgan Securiti...
PDF
May 14, 2007
REDWOOD CITY, Calif., May 14, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that it intends to offer to sell, subject to market and other conditions, 3,000,000 shares of its common stock in an underwritten public offering. The company intends to grant the underwriters an option for a peri...
PDF
May 1, 2007
REDWOOD CITY, Calif., May 1, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the first quarter ended March 31, 2007. Total revenue increased to $14.1 million in the first quarter of 2007 compared to $5.1 million in the first quarter of 2006. Pr...
PDF
Apr 24, 2007
REDWOOD CITY, Calif., April 24, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, May 1, 2007 at 4:30 p.m. Eastern Time to discuss its first quarter 2007 financial results. The call and webcast will follow the release of the...
PDF
Mar 13, 2007
REDWOOD CITY, Calif., March 13, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will present at the Lehman Brothers Tenth Annual Global Healthcare Conference in Miami, FL on Tuesday, March 20, 2007 at 9:00 a.m. ...
PDF
Feb 8, 2007
REDWOOD CITY, Calif., Feb 08, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Genomic Health's President and Chief Operating Officer, will present at the 9th Annual BIO CEO Conference in New York, NY on Tuesday, February 13, 2007 at 3:45 p.m. Eastern Time. To access t...
PDF
Feb 6, 2007
REDWOOD CITY, Calif., Feb 06, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results for the fourth quarter and year ended December 31, 2006. Total revenue increased to $8.6 million in the fourth quarter of 2006 compared to $1.9 million in the fourth quarter of 2005. Total rev...
PDF
Jan 30, 2007
REDWOOD CITY, Calif., Jan 30, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, February 6, 2007 at 4:30 p.m. Eastern Time to discuss its fourth quarter and year end 2006 financial results. The call and webcast will follow t...
PDF
Jan 10, 2007
REDWOOD CITY, Calif., Jan 10, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company has signed a national payor contract with United HealthCare Insurance Company ("UnitedHealthcare"), an affiliate of UnitedHealth Group (NYSE: UNH), for Oncotype DX, the company's test service that...
PDF
Jan 8, 2007
REDWOOD CITY, Calif., Jan 08, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that it will move one of its research projects, a test to predict the likelihood of colon cancer recurrence, into full-scale clinical development. This is the second major cancer program initiated by the company, ...
PDF
Jan 3, 2007
REDWOOD CITY, Calif., Jan 03, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will present at the 25th Annual JPMorgan Healthcare Conference in San Francisco, CA on Wednesday, January 10 at 1:30 p.m. Pacific Tim...
PDF
Dec 17, 2006
SAN ANTONIO, Dec 17, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the results of several studies looking at the roles and relationships of genes measured by the company's Oncotype DX breast cancer assay, including an analysis of more than 10,000 node-negative tumors indicating that all 2...
PDF
Dec 15, 2006
SAN ANTONIO, Dec 15, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- The National Surgical Adjuvant Breast and Bowel Project (NSABP) and Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results of a new study that compared measurement of estrogen receptor (ER) expression by three methods, including quantitative ER expression as m...
PDF
Dec 8, 2006
REDWOOD CITY, Calif., December 8, 2006 -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results regarding the company's Oncotype DX™ breast cancer test, which quantifies the likelihood of recurrence and predicts the likelihood of chemotherapy benefit for a large portion of early-stage breast ca...
PDF
Nov 28, 2006
REDWOOD CITY, Calif., Nov 28, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company has signed a national contract with Aetna for Oncotype DX, the company's test service that quantifies the likelihood of breast cancer recurrence and predicts the likelihood of chemotherapy benefit...
PDF
Nov 20, 2006
REDWOOD CITY, Calif., Nov 20, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will present at the Piper Jaffray Health Care Conference in New York, NY on November 29, 2006 at 11:00 a.m. Eastern Time. To acce...
PDF
Nov 9, 2006
REDWOOD CITY, Calif., Nov 09, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Genomic Health's President and Chief Operating Officer, will present at the JPMorgan Small/Mid- Cap Conference in Boston, MA on Wednesday, November 15 at 9:30 a.m. Eastern Time. Ms. Popovits...
PDF
Nov 2, 2006
REDWOOD CITY, Calif., Nov 02, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results for the third quarter and nine months ended September 30, 2006. Total revenue was $7.1 million in the third quarter of 2006, compared to $1.6 million in the third quarter of 2005. Oncotype DX ...
PDF
Oct 26, 2006
REDWOOD CITY, Calif., Oct 26, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Thursday, November 2, 2006 at 4:30 p.m. Eastern Time to discuss its third quarter financial results. The call and webcast will follow the release of the ...
PDF
Oct 12, 2006
REDWOOD CITY, Calif., Oct 12, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Genomic Health's Chief Operating Officer, will participate in a panel discussion titled "Molecular Diagnostics -- Today and in the Future" at the BIO InvestorForum 2006 in San Francisco, CA on T...
PDF
Sep 20, 2006
REDWOOD CITY, Calif., Sept 20, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will present at the UBS Global Life Sciences Conference in New York, NY on September 25, 2006 at 4:30 p.m. Eastern Time. To acce...
PDF
Sep 6, 2006
REDWOOD CITY, Calif., Sept 06, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today provided initial comment on the U.S. Food and Drug Administration's (FDA) draft guidance on "In Vitro Diagnostic Multivariate Index Assays." "This draft guidance represents the first public discussion surrounding the A...
PDF
Sep 1, 2006
REDWOOD CITY, Calif., Sept 01, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will present at the Thomas Weisel Partners Healthcare Conference in Boston, MA on Wednesday, September 6 at 3:50 PM Eastern Time. ...
PDF
Aug 1, 2006
REDWOOD CITY, Calif., Aug 01, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results for the second quarter and six months ended June 30, 2006. Total revenue was $8.4 million in the second quarter of 2006, compared to $1.2 million in the second quarter of 2005. Oncotype DX pro...
PDF
Jul 25, 2006
REDWOOD CITY, Calif., July 25, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, August 1, 2006 at 4:30 p.m. Eastern Time to discuss its second quarter financial results. The call and webcast will follow the release of the s...
PDF
Jun 8, 2006
REDWOOD CITY, Calif., June 8, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Genomic Health's President and Chief Operating Officer, will present at the 2006 Pacific Growth Equities Life Sciences Growth Conference in San Francisco, CA on Tuesday, June 13 at 4:00 p.m. Pa...
PDF
Jun 6, 2006
ATLANTA, June 6, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results from two studies that further demonstrate the value and clinical utility of quantifying gene expression to individualize treatment planning for early-stage breast cancer patients. These studies, along with fi...
PDF
Jun 4, 2006
ATLANTA, June 4, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- The Pittsburgh-based National Surgical Adjuvant Breast and Bowel Project (NSABP) and Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results of a new study that identified genes associated with prognosis in patients with stage II and III colon cancer treated with ...
PDF
Jun 2, 2006
REDWOOD CITY, Calif., June 2, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced three poster presentations scheduled for the Annual Meeting of the American Society of Clinical Oncology taking place in Atlanta, GA, from June 2 - 6, 2006. Following are details for each embargoed session: S...
PDF
May 31, 2006
REDWOOD CITY, Calif., May 31, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the journal Breast Cancer Research published results from a large clinical study conducted by Kaiser Permanente confirming that Oncotype DX, the company's breast cancer test service, also helps predict the l...
PDF
May 23, 2006
REDWOOD CITY, Calif. – May 23, 2006 – Genomic Health, Inc. (Nasdaq: GHDX) today announced that the Journal of Clinical Oncology (JCO) published results of a large-scale trial conducted with the National Surgical Adjuvant Breast and Bowel Project (NSABP) confirming the Oncotype DX 21-gene panel, which quantifies the risk of breast cancer r...
PDF
May 10, 2006
REDWOOD CITY, Calif., May 10, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will present at the 2006 Bank of America Health Care Conference in Las Vegas, NV on Wednesday, May 17 at 2:40 PM (5:40 PM Eastern Ti...
PDF
May 2, 2006
REDWOOD CITY, Calif., May 2, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and updated its business progress for the first quarter ended March 31, 2006. Total revenue increased to $5.1 million in the first quarter of 2006 versus $0.4 million in the first quarter of 2...
PDF
Apr 25, 2006
REDWOOD CITY, Calif., April 25, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, May 2, 2006 at 4:30 p.m. Eastern Time to discuss its first quarter financial results. The call and webcast will follow the release of the fir...
PDF
Apr 11, 2006
REDWOOD CITY, Calif., April 11, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the appointment of Woodrow A. Myers, M.D., M.B.A. to its board of directors. Dr. Myers, a director at Stanford University Hospital and visiting adjunct professor of medicine at the UCLA School of Medicine, is t...
PDF
Apr 7, 2006
REDWOOD CITY, Calif., April 7, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will participate in a panel discussion titled, "The Transformation of the Biomedical Marketplace," at the BIO 2006 National Convent...
PDF
Mar 23, 2006
REDWOOD CITY, Calif., March 23, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will present at Thomson Financial and BioCentury's Future Leaders in the Biotech Industry Conference in New York on Thursday, Marc...
PDF
Mar 2, 2006
REDWOOD CITY, Calif., March 2, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, the Company's President and Chief Operating Officer, will present at the JMP Securities Research Conference in San Francisco, CA on Tuesday, March 7, 2006 at 3:15 p.m. Pacific Time. The Co...
PDF
Feb 13, 2006
Feb 13, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results for the fourth quarter and year ended December 31, 2005. Total revenue increased to $1.9 million in the fourth quarter of 2005 versus $0.1 million in the fourth quarter of 2004 and $1.6 million in the third quarte...
PDF
Feb 10, 2006
REDWOOD CITY, Calif., Feb 10, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., the Company's Chairman and Chief Executive Officer will present at the 2006 BIO CEO & Investor Conference on Wednesday, February 15, 2006 at 10:00 a.m. Eastern at the Waldorf-Astoria in N...
PDF
Feb 6, 2006
REDWOOD CITY, Calif., Feb 06, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Monday, February 13, 2006 at 4:30 PM Eastern Time to discuss its fourth quarter and year end 2005 financial results. The call and webcast will follow th...
PDF
Jan 27, 2006
REDWOOD CITY, Calif., Jan 27, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) announced today that it has received a letter from the Food and Drug Administration (FDA) regarding Oncotype DX(TM), the company's genomic-based test for early stage breast cancer patients. The letter invited the company to meet...
PDF
Jan 13, 2006
REDWOOD CITY, Calif., Jan 13, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the National Heritage Insurance Company (NHIC), the contractor that administers Medicare programs in California, has established a positive coverage policy for the company's Oncotype DX(TM) breast cancer tes...
PDF
Jan 5, 2006
REDWOOD CITY, Calif., Jan 05, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., the Company's Chairman and Chief Executive Officer, will present at the 24th Annual JPMorgan Healthcare Conference on Monday, January 9, 2006 at 3:30 PM Pacific (6:30 PM Eastern) at the W...
PDF
Dec 10, 2005
SAN ANTONIO, Dec 10, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results from a new analysis demonstrating that the same Oncotype DX(TM) Recurrence Score(TM) that quantifies distant recurrence for a large portion of early-stage breast cancer patients is also a significant pred...
PDF
Dec 9, 2005
SAN ANTONIO, Dec 09, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of a community-based, investigator-sponsored study that demonstrated its Oncotype DX(TM) 21-gene panel breast cancer test, which quantifies the likelihood of recurrence and predicts chemotherapy benefit for a larg...
PDF
Dec 5, 2005
REDWOOD CITY, Calif., Dec 05, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) announced today that results from three new analyses of the company's Oncotype DX(TM) breast cancer test, which quantifies the likelihood of recurrence and predicts chemotherapy benefit for a large portion of early stage breast ...
PDF
Nov 3, 2005
REDWOOD CITY, Calif., Nov 03, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results for the third quarter and nine months ended September 30, 2005. Total revenue was $1,592,000 in the third quarter of 2005, compared to $167,000 in the third quarter of 2004, driven by growth of O...
PDF
Oct 28, 2005
REDWOOD CITY, Calif., Oct 28, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Thursday, November 3 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss its third quarter 2005 financial results. The call and webcast will foll...
PDF
Sep 28, 2005
REDWOOD CITY, Calif., Sept. 28, 2005 /PRNewswire-FirstCall/ -- Genomic Health, Inc. today announced the pricing of its initial public offering of 5,016,722 shares of its Common Stock at $12.00 per share. J.P. Morgan Securities Inc. and Lehman Brothers Inc. acted as joint book-running managers for this offering, and Piper Jaffray & Co., Thomas Weise...
PDF
May 17, 2005
ORLANDO - May 17, 2005 - Genomic Health, Inc. announced that results from three independent studies evaluating the Oncotype DX breast cancer assay were presented at the 41st annual meeting of the American Society of Clinical Oncology (ASCO). These studies examined the assay's ability to quantify likelihood of recurrence, predict response to c...
PDF
May 13, 2005
REDWOOD CITY, CA - May 13, 2005 - Genomic Health, Inc. today announced that The American Journal of Managed Care published the results of a comprehensive economic analysis demonstrating that the breast cancer assay, Oncotype DX, which measures gene expression for a 21-gene panel from individual tumor specimens, may improve survival for some pa...
PDF
Dec 10, 2004
A new test can predict both the risk of breast cancer recurrence and may identify women who will benefit most from chemotherapy, according to research supported by the National Cancer Institute (NCI), part of the National Institutes of Health, and performed in collaboration with the National Surgical Adjuvant Breast and Bowel Project (NSABP) a...
PDF
Dec 10, 2004
NSABP and Genomic Health Announce Positive Study Results Demonstrating Oncotype DX Genomic Breast Cancer Assay Predicts Chemotherapy Response ...
PDF
Dec 9, 2004
SAN ANTONIO - Kaiser Permanente researchers are presenting results of a large epidemiologic study of a unique breast cancer test at the 27th Annual San Antonio Breast Cancer Symposium. The KP study shows the test can identify patients with early stage disease who are at low risk of breast cancer death at 10 years. Researchers at Kais...
PDF
Jun 5, 2004
NEW ORLEANS - June 5, 2004 - Genomic Health, Inc. and Istituto Nazionale Tumori, a leading cancer research institute located in Milan, Italy, today announced preliminary results of a clinical trial in which the patterns of expression of a substantial number of genes were clinically correlated to a pathologic complete response to chemotherapy. The s...
PDF
Dec 4, 2003
The NSABP and Genomic Health Announce Positive Results from Large-Scale, Prospective Validation Study to Quantify Breast Cancer Recurrence in Newly Diagnosed Patients ...
PDF
Jun 2, 2003
Collaborator Press Release: Early Studies With Molecular Test Show That Specific Gene Patterns Are Linked To Response To Treatment With Potent EGFR Drug In Patients With Advanced Lung Cancer ...
PDF
Jun 2, 2003
CHICAGO June 2, 2003 — Genomic Health, Inc. today announced encouraging preliminary data in clinical trials using a novel approach to molecular pathology. RNA analysis of thin sections of standard tumor biopsies were used to evaluate panels of genes that may predict breast cancer recurrence and response to chemotherapy as well as response...
PDF
May 31, 2003
CHICAGO May 31, 2003 — Most breast cancer patients with more than 10 nodes that are affected by the cancer have a poor prognosis, yet some survive long-term. Physicians now believe that certain genes in the breast cancer tissue, removed at diagnosis, can help them predict which patients will survive. With this information...
PDF